Influenza vaccine (English Wikipedia)

Product Monograph: Flumist (PDF), Astrazeneca Canada Inc., June 20, 2014, archived (PDF) from the original on September 30, 2020, retrieved September 5, 2020

bbc.com

Triggle N (October 8, 2021). "Flu jab vital this winter along with Covid vaccine". BBC News. Archived from the original on November 14, 2021. Retrieved August 13, 2022.

biospace.com

Keown A (February 4, 2020). "FDA Approves Seqirus' Audenz as Vaccine Against Potential Flu Pandemic". BioSpace. Archived from the original on February 5, 2020. Retrieved February 5, 2020.

books.google.com

Compans RW (2009). Vaccines for pandemic influenza. Dordrecht: Springer. p. 49. ISBN 978-3-540-92165-3. Archived from the original on August 3, 2020. Retrieved September 9, 2017.
Vaccine Analysis: Strategies, Principles, and Control. Springer. 2014. p. 61. ISBN 978-3-662-45024-6. Archived from the original on August 3, 2020. Retrieved September 9, 2017.

cadth.ca

Wells C, Grobelna A (January 8, 2019). "High Dose Influenza Vaccine for Adults: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines" (PDF). Rapid Response Report. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). ISSN 1922-8147. PMID 31141324. Archived (PDF) from the original on August 1, 2020. Retrieved August 15, 2022.

canada.ca

Gemmill I, Young K (June 7, 2018). "Summary of the NACI literature review on the comparative effectiveness of subunit and split virus inactivated influenza vaccines in older adults". Canada Communicable Disease Report. 44 (6): 129–133. doi:10.14745/ccdr.v44i06a02. ISSN 1481-8531. PMC 6449119. PMID 31015805. Archived from the original on May 17, 2020. Retrieved June 2, 2020.
National Advisory Committee on Immunization (NACI) (November 2018). "Supplemental Statement – Afluria Tetra – An Advisory Committee Statement (ACS)". Public Health Agency of Canada. Ottawa. Cat.: HP37-25E-PDF Pub.: 180566. Archived from the original on January 12, 2020. Retrieved January 11, 2020.
Literature Review on Pediatric Fluad Influenza Vaccine Use in Children 6–72 Months of Age (PDF) (Report). Ottawa: Public Health Agency of Canada. 2015. Archived (PDF) from the original on May 17, 2020. Retrieved January 11, 2020.
Camilloni B, Basileo M, Valente S, Nunzi E, Iorio AM (2015). "Immunogenicity of intramuscular MF59-adjuvanted and intradermal administered influenza enhanced vaccines in subjects aged over 60: A literature review". Human Vaccines & Immunotherapeutics. 11 (3): 553–63. doi:10.1080/21645515.2015.1011562. PMC 4514405. PMID 25714138.
- Lay summary in: "Literature Review Update on the Efficacy and Effectiveness of High-Dose (Fluzone High-Dose) and MF59-Adjuvanted (Fluad) Trivalent Inactivated Influenza Vaccines in Adults 65 Years of Age and Older". Public Health Agency of Canada. May 1, 2018.
- Canadian Immunization Guide Chapter on Influenza and Statement on Seasonal Influenza Vaccine for 2019–2020 (PDF) (Report). Public Health Agency of Canada. May 2019. Cat.: HP37-25E-PDF; Pub.: 180883. Archived (PDF) from the original on July 16, 2020. Retrieved June 2, 2020.

cdc.gov

"Who Should and Who Should NOT get a Flu Vaccine". U.S. Centers for Disease Control and Prevention (CDC). October 11, 2019. Archived from the original on December 2, 2019. Retrieved December 2, 2019. This article incorporates text from this source, which is in the public domain.
Grohskopf LA, Alyanak E, Ferdinands JM, Broder KR, Blanton LH, Talbot HK, et al. (August 2021). "Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season" (PDF). MMWR Recomm Rep. 70 (5): 1–28. doi:10.15585/mmwr.rr7005a1. PMC 8407757. PMID 34448800. Archived (PDF) from the original on August 27, 2021. Retrieved August 29, 2021. This article incorporates text from this source, which is in the public domain.
"Flu Vaccine and People with Egg Allergies". U.S. Centers for Disease Control and Prevention (CDC). November 25, 2019. Archived from the original on December 2, 2019. Retrieved December 2, 2019. This article incorporates text from this source, which is in the public domain.
"Intradermal Influenza (Flu) Vaccination". U.S. Centers for Disease Control and Prevention (CDC). October 31, 2018. Archived from the original on October 14, 2019. Retrieved October 14, 2019. This article incorporates text from this source, which is in the public domain.
"Influenza vaccines – United States, 2019–20 influenza season". U.S. Centers for Disease Control and Prevention (CDC). August 22, 2019. Archived from the original on October 14, 2019. Retrieved October 14, 2019. This article incorporates text from this source, which is in the public domain.
"Cell-Based Flu Vaccines". U.S. Centers for Disease Control and Prevention (CDC). October 11, 2019. Archived from the original on December 2, 2019. Retrieved December 2, 2019. This article incorporates text from this source, which is in the public domain.
"What You Should Know for the 2018-2019 Influenza Season". Centers for Disease Control and Prevention (CDC). January 10, 2019. Archived from the original on August 6, 2020. Retrieved February 5, 2020. This article incorporates text from this source, which is in the public domain.
"Frequently Asked Influenza (Flu) Questions: 2019–2020 Season". U.S. Centers for Disease Control and Prevention (CDC). November 5, 2019. Archived from the original on December 1, 2019. Retrieved November 30, 2019. This article incorporates text from this source, which is in the public domain.
"Key Facts About Seasonal Flu Vaccine". U.S. Centers for Disease Control and Prevention (CDC). December 2, 2019. Archived from the original on December 2, 2019. Retrieved December 2, 2019. This article incorporates text from this source, which is in the public domain.
"Past Seasons Vaccine Effectiveness Estimates". U.S. Centers for Disease Control and Prevention (CDC). January 29, 2020. Archived from the original on February 12, 2020. Retrieved March 4, 2019. This article incorporates text from this source, which is in the public domain.
Centers for Disease Control Prevention (CDC) (August 13, 2004). "Assessment of the effectiveness of the 2003-04 influenza vaccine among children and adults--Colorado, 2003". MMWR. Morbidity and Mortality Weekly Report. 53 (31). Centers for Disease Control and Prevention: 707–710. ISSN 1545-861X. PMID 15306754. Archived from the original on April 27, 2022. Retrieved April 27, 2022. At table.
Centers for Disease Control Prevention (CDC) (January 16, 2004). "Preliminary assessment of the effectiveness of the 2003-04 inactivated influenza vaccine--Colorado, December 2003". MMWR. Morbidity and Mortality Weekly Report. 53 (1). Centers for Disease Control and Prevention: 8–11. ISSN 1545-861X. PMID 14724559. Archived from the original on May 29, 2022. Retrieved April 25, 2022.
"Past Weekly Surveillance Reports". Centers for Disease Control and Prevention. April 29, 2022. Archived from the original on April 22, 2022. Retrieved April 25, 2022.
Chung JR (March 11, 2022). "Interim Estimates of 2021–22 Seasonal Influenza Vaccine Effectiveness — United States, February 2022". MMWR. Morbidity and Mortality Weekly Report. 71 (10): 365–370. doi:10.15585/mmwr.mm7110a1. ISSN 0149-2195. PMC 8911998. PMID 35271561. Archived from the original on May 16, 2022. Retrieved May 25, 2022.
"2007–2008 Influenza (Flu) Season". U.S. Centers for Disease Control and Prevention (CDC). June 26, 2008. Archived from the original on March 6, 2008. This article incorporates text from this source, which is in the public domain.
"Vaccine Effectiveness: How Well Do the Flu Vaccines Work?". U.S. Centers for Disease Control and Prevention (CDC). October 12, 2018. Archived from the original on October 25, 2019. Retrieved October 24, 2019. This article incorporates text from this source, which is in the public domain.
"Flu & People 65 Years and Older". Centers for Disease Control and Prevention. August 26, 2021. Archived from the original on April 22, 2022. Retrieved April 21, 2022.
"Influenza Historic Timeline | Pandemic Influenza (Flu) | CDC". March 11, 2020. Archived from the original on January 30, 2022. Retrieved January 27, 2022.
"Study of Flu-Related Deaths in Children Shows Healthy Children at Risk". U.S. Centers for Disease Control and Prevention (CDC). February 12, 2018. Archived from the original on December 2, 2019. Retrieved December 2, 2019. This article incorporates text from this source, which is in the public domain.
"Fluzone High-Dose Seasonal Influenza Vaccine". U.S. Centers for Disease Control and Prevention (CDC). September 6, 2019. Archived from the original on December 2, 2019. Retrieved December 2, 2019.
"Flu Vaccine With Adjuvant". U.S. Centers for Disease Control and Prevention (CDC). September 4, 2019. Archived from the original on December 2, 2019. Retrieved December 2, 2019. This article incorporates text from this source, which is in the public domain.
"Flu shot". CDC. 2020. Archived from the original on December 2, 2019. Retrieved September 24, 2020.
"Misconceptions about flu vaccines". CDC. 2020. Archived from the original on August 10, 2020. Retrieved September 24, 2020.
"Thimerosal in Flu Vaccine". U.S. Centers for Disease Control and Prevention. October 16, 2015. Archived from the original on December 2, 2019. Retrieved December 2, 2019. This article incorporates text from this source, which is in the public domain.
"Thimerosal in Vaccines Thimerosal – Concerns – Vaccine Safety". U.S. Centers for Disease Control and Prevention. October 27, 2015. Archived from the original on November 2, 2019. Retrieved December 2, 2019. This article incorporates text from this source, which is in the public domain.
"Seasonal Flu Shot". U.S. Centers for Disease Control and Prevention (CDC). December 9, 2019. Archived from the original on December 2, 2019. Retrieved January 12, 2020. This article incorporates text from this source, which is in the public domain.
"Children & Influenza (Flu)". U.S. Centers for Disease Control and Prevention (CDC). October 23, 2019. Archived from the original on November 11, 2019. This article incorporates text from this source, which is in the public domain.
"Live Attenuated Influenza Vaccine [LAIV] (The Nasal Spray Flu Vaccine)". U.S. Centers for Disease Control and Prevention (CDC). September 16, 2019. Archived from the original on October 14, 2019. Retrieved October 14, 2019. This article incorporates text from this source, which is in the public domain.
"Influenza Vaccination: A Summary for Clinicians – Health Professionals – Seasonal Influenza (Flu)". U.S. Centers for Disease Control and Prevention (CDC). September 6, 2018. Archived from the original on February 24, 2008. This article incorporates text from this source, which is in the public domain.
Centers for Disease Control Prevention (CDC) (December 2010). "Seasonal influenza and 2009 H1N1 influenza vaccination coverage among pregnant women – 10 states, 2009–10 influenza season" (PDF). Morbidity and Mortality Weekly Report (MMWR). 59 (47): 1541–45. PMID 21124293. Archived (PDF) from the original on June 25, 2017. This article incorporates text from this source, which is in the public domain.
"ACIP votes down use of LAIV for 2016–2017 flu season" (Press release). U.S. Centers for Disease Control and Prevention (CDC). June 22, 2016. Archived from the original on November 25, 2016. Retrieved November 26, 2016. This article incorporates text from this source, which is in the public domain.
"Immunization Schedules". U.S. Centers for Disease Control and Prevention (CDC). Archived from the original on November 5, 2014. Retrieved November 4, 2014. This article incorporates text from this source, which is in the public domain.
Centers for Disease Control Prevention (CDC) (October 2009). "Update on influenza A (H1N1) 2009 monovalent vaccines" (PDF). Morbidity and Mortality Weekly Report (MMWR). 58 (39): 1100–01. PMID 19816398. Archived (PDF) from the original on June 29, 2011. This article incorporates text from this source, which is in the public domain.
Centers for Disease Control Prevention (CDC) (August 2011). "Influenza vaccination coverage among health-care personnel – United States, 2010–11 influenza season" (PDF). Morbidity and Mortality Weekly Report (MMWR). 60 (32): 1073–77. PMID 21849963. Archived (PDF) from the original on May 25, 2017. This article incorporates text from this source, which is in the public domain.
Centers for Disease Control Prevention (CDC) (September 2012). "Influenza vaccination coverage among health-care personnel: 2011–12 influenza season, United States" (PDF). Morbidity and Mortality Weekly Report (MMWR). 61: 753–57. PMID 23013720. Archived (PDF) from the original on June 24, 2017. This article incorporates text from this source, which is in the public domain.
"How Influenza (Flu) Vaccines Are Made". U.S. Centers for Disease Control and Prevention (CDC). November 26, 2019. Archived from the original on December 2, 2019. Retrieved December 2, 2019. This article incorporates text from this source, which is in the public domain.

clinicaltrials.gov

Clinical trial number NCT00776711 for "Vaccine for Prevention of Bird Flu" at ClinicalTrials.gov
Clinical trial number NCT01086657 for "An Open-Label, Randomized Phase I Study in Healthy Adults of the Safety and Immunogenicity of Prime-Boost Intervals with Monovalent Influenza Subunit Virion (H5N1) Vaccine, A/Indonesia/05/2005 (Sanofi Pasteur, Inc), Administered Alone or Following Recombinant DNA Plasmid (H5) Vaccine, VRC-AVIDNA036-00-VP (VRC, NIAID)" at ClinicalTrials.gov

doi.org

Manzoli L, Ioannidis JP, Flacco ME, De Vito C, Villari P (July 2012). "Effectiveness and harms of seasonal and pandemic influenza vaccines in children, adults and elderly: a critical review and re-analysis of 15 meta-analyses". Human Vaccines & Immunotherapeutics. 8 (7): 851–62. doi:10.4161/hv.19917. PMC 3495721. PMID 22777099.
Grohskopf LA, Alyanak E, Ferdinands JM, Broder KR, Blanton LH, Talbot HK, et al. (August 2021). "Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season" (PDF). MMWR Recomm Rep. 70 (5): 1–28. doi:10.15585/mmwr.rr7005a1. PMC 8407757. PMID 34448800. Archived (PDF) from the original on August 27, 2021. Retrieved August 29, 2021. This article incorporates text from this source, which is in the public domain.
Institute of Medicine (2005). Knobler SL, Mack A, Mahmoud A, Lemon SM (eds.). The Threat of Pandemic Influenza: Are We Ready? Workshop Summary. The National Academies Press. p. 62. doi:10.17226/11150. ISBN 978-0-309-09504-4. PMID 20669448.
Hampson AW (June 2008). "Vaccines for pandemic influenza. The history of our current vaccines, their limitations and the requirements to deal with a pandemic threat". Annals of the Academy of Medicine, Singapore. 37 (6): 510–17. doi:10.47102/annals-acadmedsg.V37N6p510. PMID 18618064. S2CID 17102174.
Milián E, Kamen AA (2015). "Current and emerging cell culture manufacturing technologies for influenza vaccines". Biomed Res Int. 2015: 504831. doi:10.1155/2015/504831. PMC 4359798. PMID 25815321.
Landry N, Ward BJ, Trépanier S, Montomoli E, Dargis M, Lapini G, et al. (December 2010). "Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza". PLOS ONE. 5 (12): e15559. Bibcode:2010PLoSO...515559L. doi:10.1371/journal.pone.0015559. PMC 3008737. PMID 21203523.
Osterholm MT (May 2005). "Preparing for the next pandemic". The New England Journal of Medicine. 352 (18): 1839–42. CiteSeerX 10.1.1.608.6200. doi:10.1056/NEJMp058068. PMID 15872196. S2CID 45893174.
McCullers JA, Van De Velde LA, Allison KJ, Branum KC, Webby RJ, Flynn PM (June 2010). "Recipients of vaccine against the 1976 "swine flu" have enhanced neutralization responses to the 2009 novel H1N1 influenza virus". Clinical Infectious Diseases. 50 (11): 1487–92. doi:10.1086/652441. PMC 2946351. PMID 20415539.
Doshi P (September 20, 2018). "Pandemrix vaccine: why was the public not told of early warning signs?". BMJ. 362: k3948. doi:10.1136/bmj.k3948. ISSN 0959-8138. S2CID 52308748.
Doshi P (September 20, 2018). "Pandemrix vaccine: why was the public not told of early warning signs?". BMJ. 362: Infographic. doi:10.1136/bmj.k3948. S2CID 52308748.
Koutsakos M, Wheatley AK, Laurie K, Kent SJ, Rockman S (December 2021). "Influenza lineage extinction during the COVID-19 pandemic?". Nature Reviews. Microbiology. 19 (12): 741–742. doi:10.1038/s41579-021-00642-4. PMC 8477979. PMID 34584246.
Osterholm MT, Kelley NS, Sommer A, Belongia EA (January 2012). "Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis". The Lancet. Infectious Diseases. 12 (1): 36–44. doi:10.1016/s1473-3099(11)70295-x. PMID 22032844.
MacIntyre CR, Mahimbo A, Moa AM, Barnes M (December 2016). "Influenza vaccine as a coronary intervention for prevention of myocardial infarction". Heart. 102 (24): 1953–1956. doi:10.1136/heartjnl-2016-309983. PMC 5256393. PMID 27686519.
Chung JR (March 11, 2022). "Interim Estimates of 2021–22 Seasonal Influenza Vaccine Effectiveness — United States, February 2022". MMWR. Morbidity and Mortality Weekly Report. 71 (10): 365–370. doi:10.15585/mmwr.mm7110a1. ISSN 0149-2195. PMC 8911998. PMID 35271561. Archived from the original on May 16, 2022. Retrieved May 25, 2022.
Demicheli V, Jefferson T, Ferroni E, Rivetti A, Di Pietrantonj C (February 2018). "Vaccines for preventing influenza in healthy adults". Cochrane Database of Systematic Reviews. 2020 (2): CD001269. doi:10.1002/14651858.CD001269.pub6. PMC 6491184. PMID 29388196.
Jefferson T (October 2006). "Influenza vaccination: policy versus evidence". BMJ. 333 (7574): 912–15. doi:10.1136/bmj.38995.531701.80. PMC 1626345. PMID 17068038.
Carrat F, Flahault A (September 2007). "Influenza vaccine: the challenge of antigenic drift". Vaccine. 25 (39–40): 6852–6862. doi:10.1016/j.vaccine.2007.07.027. PMID 17719149.
Sautto GA, Kirchenbaum GA, Ross TM (January 19, 2018). "Towards a universal influenza vaccine: different approaches for one goal". Virology Journal. 15 (1): 17. doi:10.1186/s12985-017-0918-y. PMC 5785881. PMID 29370862.
Chow EJ, Doyle JD, Uyeki TM (June 12, 2019). "Influenza virus-related critical illness: prevention, diagnosis, treatment". Critical Care. 23 (1): 214. doi:10.1186/s13054-019-2491-9. PMC 6563376. PMID 31189475.
Krammer F, Smith GJ, Fouchier RA, Peiris M, Kedzierska K, Doherty PC, et al. (June 28, 2018). "Influenza". Nature Reviews Disease Primers. 4 (1): 3. doi:10.1038/s41572-018-0002-y. PMC 7097467. PMID 29955068.
Dabestani NM, Leidner AJ, Seiber EE, Kim H, Graitcer SB, Foppa IM, et al. (September 2019). "A review of the cost-effectiveness of adult influenza vaccination and other preventive services". Preventive Medicine. 126: 105734. doi:10.1016/j.ypmed.2019.05.022. PMC 6778688. PMID 31152830.
Ghebrehewet S, MacPherson P, Ho A (December 7, 2016). "Influenza". The BMJ. 355: i6258. doi:10.1136/bmj.i6258. PMC 5141587. PMID 27927672.
Principi N, Esposito S (March 4, 2018). "Protection of children against influenza: Emerging problems". Human Vaccines & Immunotherapeutics. 14 (3): 750–757. doi:10.1080/21645515.2017.1279772. PMC 5861800. PMID 28129049.
Thompson MG, Pierse N, Huang QS, Prasad N, Duque J, Newbern EC, et al. (September 18, 2018). "Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012–2015". Vaccine. 36 (39): 5916–5925. doi:10.1016/j.vaccine.2018.07.028. ISSN 0264-410X. PMID 30077480. S2CID 51922011. Archived from the original on May 27, 2022. Retrieved April 23, 2022.
Tenforde MW, Talbot HK, Trabue CH, Gaglani M, McNeal TS, Monto AS, et al. (December 30, 2020). "Influenza Vaccine Effectiveness Against Hospitalization in the United States, 2019–2020". The Journal of Infectious Diseases. 224 (5): 813–820. doi:10.1093/infdis/jiaa800. ISSN 0022-1899. PMC 8408767. PMID 33378531. Archived from the original on April 23, 2022. Retrieved April 23, 2022.
Ferdinands JM, Thompson MG, Blanton L, Spencer S, Grant L, Fry AM (June 23, 2021). "Does influenza vaccination attenuate the severity of breakthrough infections? A narrative review and recommendations for further research". Vaccine. 39 (28): 3678–3695. doi:10.1016/j.vaccine.2021.05.011. ISSN 0264-410X. PMID 34090700. S2CID 235361401. Archived from the original on April 23, 2022. Retrieved April 23, 2022.
Ramsay LC, Buchan SA, Stirling RG, Cowling BJ, Feng S, Kwong JC, et al. (January 2019). "The impact of repeated vaccination on influenza vaccine effectiveness: a systematic review and meta-analysis". BMC Med. 17 (1): 9. doi:10.1186/s12916-018-1239-8. PMC 6327561. PMID 30626399.
Belongia EA, Skowronski DM, McLean HQ, Chambers C, Sundaram ME, De Serres G (July 2017). "Repeated annual influenza vaccination and vaccine effectiveness: review of evidence". Expert Rev Vaccines. 16 (7): 723–36. doi:10.1080/14760584.2017.1334554. PMID 28562111.
Gemmill I, Young K (June 7, 2018). "Summary of the NACI literature review on the comparative effectiveness of subunit and split virus inactivated influenza vaccines in older adults". Canada Communicable Disease Report. 44 (6): 129–133. doi:10.14745/ccdr.v44i06a02. ISSN 1481-8531. PMC 6449119. PMID 31015805. Archived from the original on May 17, 2020. Retrieved June 2, 2020.
MacIntyre CR, Mahimbo A, Moa AM, Barnes M (December 2016). "Influenza vaccine as a coronary intervention for prevention of myocardial infarction". Heart. 102 (24): 1953–1956. doi:10.1136/heartjnl-2016-309983. PMC 5256393. PMID 27686519.
Jefferson T, Rivetti A, Di Pietrantonj C, Demicheli V (February 2018). "Vaccines for preventing influenza in healthy children". Cochrane Database of Systematic Reviews. 2018 (2): CD004879. doi:10.1002/14651858.CD004879.pub5. PMC 6491174. PMID 29388195.
Peleg N, Zevit N, Shamir R, Chodick G, Levy I (January 2015). "Seasonal influenza vaccination rates and reasons for non-vaccination in children with gastrointestinal disorders". Vaccine. 33 (1): 182–186. doi:10.1016/j.vaccine.2014.10.086. PMID 25444802.
Osterholm MT, Kelley NS, Sommer A, Belongia EA (January 2012). "Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis". The Lancet. Infectious Diseases. 12 (1): 36–44. doi:10.1016/S1473-3099(11)70295-X. PMID 22032844.
Burls A, Jordan R, Barton P, Olowokure B, Wake B, Albon E, et al. (May 2006). "Vaccinating healthcare workers against influenza to protect the vulnerable – is it a good use of healthcare resources? A systematic review of the evidence and an economic evaluation". Vaccine. 24 (19): 4212–21. doi:10.1016/j.vaccine.2005.12.043. PMID 16546308.
Ahmed F, Lindley MC, Allred N, Weinbaum CM, Grohskopf L (January 2014). "Effect of influenza vaccination of healthcare personnel on morbidity and mortality among patients: systematic review and grading of evidence". Clinical Infectious Diseases. 58 (1): 50–57. doi:10.1093/cid/cit580. PMID 24046301.
Griffin MR (January 2014). "Influenza vaccination of healthcare workers: making the grade for action". Clinical Infectious Diseases. 58 (1): 58–60. doi:10.1093/cid/cit590. PMID 24046312.
Simonsen L, Viboud C, Taylor RJ, Miller MA, Jackson L (October 2009). "Influenza vaccination and mortality benefits: new insights, new opportunities". Vaccine. 27 (45): 6300–04. doi:10.1016/j.vaccine.2009.07.008. PMID 19840664.
Demicheli V, Jefferson T, Di Pietrantonj C, Ferroni E, Thorning S, Thomas RE, et al. (February 2018). "Vaccines for preventing influenza in the elderly". Cochrane Database of Systematic Reviews. 2 (11): CD004876. doi:10.1002/14651858.CD004876.pub4. PMC 6491101. PMID 29388197.
Darvishian M, Bijlsma MJ, Hak E, van den Heuvel ER (December 2014). "Effectiveness of seasonal influenza vaccine in community-dwelling elderly people: a meta-analysis of test-negative design case-control studies". The Lancet. Infectious Diseases. 14 (12): 1228–39. doi:10.1016/S1473-3099(14)70960-0. PMID 25455990.
Nichol KL, Nordin JD, Nelson DB, Mullooly JP, Hak E (October 2007). "Effectiveness of influenza vaccine in the community-dwelling elderly". The New England Journal of Medicine. 357 (14): 1373–81. doi:10.1056/NEJMoa070844. PMID 17914038. S2CID 14850833.
Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA (October 2007). "Mortality benefits of influenza vaccination in elderly people: an ongoing controversy". The Lancet. Infectious Diseases. 7 (10): 658–66. doi:10.1016/S1473-3099(07)70236-0. PMID 17897608.
Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, et al. (January 2003). "Mortality associated with influenza and respiratory syncytial virus in the United States". JAMA. 289 (2): 179–86. doi:10.1001/jama.289.2.179. PMID 12517228. S2CID 5018362.
DiazGranados CA, Dunning AJ, Kimmel M, Kirby D, Treanor J, Collins A, et al. (August 2014). "Efficacy of high-dose versus standard-dose influenza vaccine in older adults". The New England Journal of Medicine. 371 (7): 635–45. doi:10.1056/NEJMoa1315727. PMID 25119609. S2CID 205096393.
Camilloni B, Basileo M, Valente S, Nunzi E, Iorio AM (2015). "Immunogenicity of intramuscular MF59-adjuvanted and intradermal administered influenza enhanced vaccines in subjects aged over 60: A literature review". Human Vaccines & Immunotherapeutics. 11 (3): 553–63. doi:10.1080/21645515.2015.1011562. PMC 4514405. PMID 25714138.
- Lay summary in: "Literature Review Update on the Efficacy and Effectiveness of High-Dose (Fluzone High-Dose) and MF59-Adjuvanted (Fluad) Trivalent Inactivated Influenza Vaccines in Adults 65 Years of Age and Older". Public Health Agency of Canada. May 1, 2018.
- Van Damme P, Arnou R, Kafeja F, Fiquet A, Richard P, Thomas S, et al. (May 2010). "Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study". BMC Infectious Diseases. 10: 134. doi:10.1186/1471-2334-10-134. PMC 2895601. PMID 20504306.
- Haverkate M, D'Ancona F, Giambi C, Johansen K, Lopalco PL, Cozza V, et al. (VENICE project gatekeepers contact points collective) (May 2012). "Mandatory and recommended vaccination in the EU, Iceland and Norway: results of the VENICE 2010 survey on the ways of implementing national vaccination programmes". Euro Surveillance. 17 (22). doi:10.2807/ese.17.22.20183-en. PMID 22687916.
- Kassianos G (2015). "Willingness of European healthcare workers to undergo vaccination against seasonal influenza: current situation and suggestions for improvement". Drugs in Context. 4: 212268. doi:10.7573/dic.212268. PMC 4316812. PMID 25657810.
- Thomas RE, Jefferson T, Lasserson TJ (June 2016). "Influenza vaccination for healthcare workers who care for people aged 60 or older living in long-term care institutions". The Cochrane Database of Systematic Reviews. 2016 (6): CD005187. doi:10.1002/14651858.CD005187.pub5. PMC 8504984. PMID 27251461.
- Fell DB, Sprague AE, Liu N, Yasseen AS, Wen SW, Smith G, et al. (June 2012). "H1N1 influenza vaccination during pregnancy and fetal and neonatal outcomes". American Journal of Public Health (Submitted manuscript). 102 (6): e33–40. doi:10.2105/AJPH.2011.300606. PMC 3483960. PMID 22515877.
- Madhi SA, Cutland CL, Kuwanda L, Weinberg A, Hugo A, Jones S, et al. (September 2014). "Influenza vaccination of pregnant women and protection of their infants". The New England Journal of Medicine. 371 (10): 918–31. doi:10.1056/NEJMoa1401480. hdl:2263/42412. PMID 25184864.
- Haber P, Sejvar J, Mikaeloff Y, DeStefano F (2009). "Vaccines and Guillain-Barré syndrome". Drug Safety. 32 (4): 309–23. doi:10.2165/00002018-200932040-00005. PMID 19388722. S2CID 33670594.
- "Reorganized text". JAMA Otolaryngology–Head & Neck Surgery. 141 (5): 428. May 2015. doi:10.1001/jamaoto.2015.0540. PMID 25996397. S2CID 26612829.
- Stowe J, Andrews N, Wise L, Miller E (February 2009). "Investigation of the temporal association of Guillain-Barre syndrome with influenza vaccine and influenza-like illness using the United Kingdom General Practice Research Database". American Journal of Epidemiology. 169 (3): 382–88. doi:10.1093/aje/kwn310. PMID 19033158.
- Sivadon-Tardy V, Orlikowski D, Porcher R, Sharshar T, Durand MC, Enouf V, et al. (January 2009). "Guillain-Barré syndrome and influenza virus infection". Clinical Infectious Diseases. 48 (1): 48–56. doi:10.1086/594124. PMID 19025491.
- Vellozzi C, Burwen DR, Dobardzic A, Ball R, Walton K, Haber P (March 2009). "Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring". Vaccine. 27 (15): 2114–20. doi:10.1016/j.vaccine.2009.01.125. PMID 19356614. Archived from the original on August 1, 2020. Retrieved May 21, 2020.
- Turner PJ, Southern J, Andrews NJ, Miller E, Erlewyn-Lajeunesse M (December 2015). "Safety of live attenuated influenza vaccine in young people with egg allergy: multicentre prospective cohort study". BMJ. 351: h6291. doi:10.1136/bmj.h6291. PMC 4673102. PMID 26645895.
- Greenhawt M (December 2015). "Live attenuated influenza vaccine for children with egg allergy". BMJ. 351: h6656. doi:10.1136/bmj.h6656. PMID 26657778. S2CID 37037904.
- Yong E (2013). "Narcolepsy confirmed as autoimmune disease". Nature. doi:10.1038/nature.2013.14413. S2CID 74850662.
- Offit PA (September 2007). "Thimerosal and vaccines – a cautionary tale". The New England Journal of Medicine. 357 (13): 1278–79. doi:10.1056/NEJMp078187. PMID 17898096. S2CID 36318722.
- To KW, Lai A, Lee KC, Koh D, Lee SS (October 2016). "Increasing the coverage of influenza vaccination in healthcare workers: review of challenges and solutions". The Journal of Hospital Infection. 94 (2): 133–42. doi:10.1016/j.jhin.2016.07.003. PMID 27546456.
- Rubin GJ, Potts HW, Michie S (March 2011). "Likely uptake of swine and seasonal flu vaccines among healthcare workers. A cross-sectional analysis of UK telephone survey data". Vaccine. 29 (13): 2421–28. doi:10.1016/j.vaccine.2011.01.035. PMID 21277402.
- Couch RB, Winokur P, Brady R, Belshe R, Chen WH, Cate TR, et al. (November 2007). "Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects". Vaccine. 25 (44): 7656–63. doi:10.1016/j.vaccine.2007.08.042. PMC 2243220. PMID 17913310.
- Lee JK, Lam GK, Shin T, Kim J, Krishnan A, Greenberg DP, et al. (May 2018). "Efficacy and effectiveness of high-dose versus standard-dose influenza vaccination for older adults: a systematic review and meta-analysis". Expert Rev Vaccines. 17 (5): 435–443. doi:10.1080/14760584.2018.1471989. PMID 29715054. S2CID 21688517.
- Robertson CA, DiazGranados CA, Decker MD, Chit A, Mercer M, Greenberg DP (December 2016). "Fluzone High-Dose Influenza Vaccine". Expert Rev Vaccines. 15 (12): 1495–1505. doi:10.1080/14760584.2016.1254044. PMID 27813430.
- Han YK, Michie S, Potts HW, Rubin GJ (March 2016). "Predictors of influenza vaccine uptake during the 2009/10 influenza A H1N1v ('swine flu') pandemic: Results from five national surveys in the United Kingdom". Preventive Medicine. 84: 57–61. doi:10.1016/j.ypmed.2015.12.018. PMC 4766366. PMID 26757401.
- Bish A, Yardley L, Nicoll A, Michie S (September 2011). "Factors associated with uptake of vaccination against pandemic influenza: a systematic review". Vaccine. 29 (38): 6472–84. doi:10.1016/j.vaccine.2011.06.107. PMID 21756960.
- Brien S, Kwong JC, Buckeridge DL (February 2012). "The determinants of 2009 pandemic A/H1N1 influenza vaccination: a systematic review". Vaccine. 30 (7): 1255–64. doi:10.1016/j.vaccine.2011.12.089. PMID 22214889.
- Thomas RE, Lorenzetti DL (May 2018). "Interventions to increase influenza vaccination rates of those 60 years and older in the community". The Cochrane Database of Systematic Reviews. 5 (5): CD005188. doi:10.1002/14651858.CD005188.pub4. PMC 6494593. PMID 29845606.
- Amodio E, Anastasi G, Marsala MG, Torregrossa MV, Romano N, Firenze A (February 2011). "Vaccination against the 2009 pandemic influenza A (H1N1) among healthcare workers in the major teaching hospital of Sicily (Italy)". Vaccine. 29 (7): 1408–12. doi:10.1016/j.vaccine.2010.12.041. PMID 21199700.
- Chor JS, Ngai KL, Goggins WB, Wong MC, Wong SY, Lee N, et al. (August 2009). "Willingness of Hong Kong healthcare workers to accept pre-pandemic influenza vaccination at different WHO alert levels: two questionnaire surveys". BMJ. 339: b3391. doi:10.1136/bmj.b3391. PMC 2731837. PMID 19706937.
- Bull AL, Bennett N, Pitcher HC, Russo PL, Richards MJ (February 2007). "Influenza vaccine coverage among health care workers in Victorian public hospitals". The Medical Journal of Australia. 186 (4): 185–86. doi:10.5694/j.1326-5377.2007.tb00858.x. PMID 17309419. S2CID 25091208.
- Abbasi J (November 2019). "The Search for a Universal Flu Vaccine Heats Up". JAMA. 322 (20): 1942–1944. doi:10.1001/jama.2019.16816. PMID 31693060. S2CID 207903441.
- Nachbagauer R, Krammer F (April 2017). "Universal influenza virus vaccines and therapeutic antibodies". Clinical Microbiology and Infection. 23 (4): 222–228. doi:10.1016/j.cmi.2017.02.009. PMC 5389886. PMID 28216325.
- Bernstein DI, Guptill J, Naficy A, Nachbagauer R, Berlanda-Scorza F, Feser J, et al. (January 2020). "Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial". The Lancet. Infectious Diseases. 20 (1): 80–91. doi:10.1016/S1473-3099(19)30393-7. PMC 6928577. PMID 31630990.
- Nachbagauer R, Feser J, Naficy A, Bernstein DI, Guptill J, Walter EB, et al. (January 2021). "A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial". Nature Medicine. 27 (1): 106–114. doi:10.1038/s41591-020-1118-7. PMID 33288923.
- Bright RA, Carter DM, Daniluk S, Toapanta FR, Ahmad A, Gavrilov V, et al. (May 2007). "Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin". Vaccine. 25 (19): 3871–78. doi:10.1016/j.vaccine.2007.01.106. PMID 17337102.
- Sparrow E, Wood JG, Chadwick C, Newall AT, Torvaldsen S, Moen A, et al. (January 2021). "Global production capacity of seasonal and pandemic influenza vaccines in 2019". Vaccine. 39 (3): 512–520. doi:10.1016/j.vaccine.2020.12.018. PMC 7814984. PMID 33341308.
- Jit M, Newall AT, Beutels P (April 2013). "Key issues for estimating the impact and cost-effectiveness of seasonal influenza vaccination strategies". Human Vaccines & Immunotherapeutics. 9 (4): 834–40. doi:10.4161/hv.23637. PMC 3903903. PMID 23357859.
- Postma MJ, Baltussen RP, Palache AM, Wilschut JC (April 2006). "Further evidence for favorable cost-effectiveness of elderly influenza vaccination". Expert Review of Pharmacoeconomics & Outcomes Research. 6 (2): 215–27. doi:10.1586/14737167.6.2.215. PMID 20528557. S2CID 12765724.
- Newall AT, Kelly H, Harsley S, Scuffham PA (2009). "Cost effectiveness of influenza vaccination in older adults: a critical review of economic evaluations for the 50- to 64-year age group". PharmacoEconomics. 27 (6): 439–50. doi:10.2165/00019053-200927060-00001. PMID 19640008. S2CID 20855671.
- Newall AT, Viboud C, Wood JG (June 2010). "Influenza-attributable mortality in Australians aged more than 50 years: a comparison of different modelling approaches". Epidemiology and Infection. 138 (6): 836–42. doi:10.1017/S095026880999118X. PMID 19941685. S2CID 29939376.
- Newall AT, Dehollain JP, Creighton P, Beutels P, Wood JG (August 2013). "Understanding the cost-effectiveness of influenza vaccination in children: methodological choices and seasonal variability". PharmacoEconomics. 31 (8): 693–702. doi:10.1007/s40273-013-0060-7. PMID 23645539. S2CID 8616720.
- Newall AT, Scuffham PA (December 2011). "Uncertainty and variability in influenza cost-effectiveness models". Australian and New Zealand Journal of Public Health. 35 (6): 576, author reply 576–77. doi:10.1111/j.1753-6405.2011.00788.x. PMID 22151168. S2CID 22402257.
- Gatwood J, Meltzer MI, Messonnier M, Ortega-Sanchez IR, Balkrishnan R, Prosser LA (January 2012). "Seasonal influenza vaccination of healthy working-age adults: a review of economic evaluations". Drugs. 72 (1): 35–48. doi:10.2165/11597310-000000000-00000. PMID 22191794. S2CID 46305863.
- Newall AT, Jit M, Beutels P (August 2012). "Economic evaluations of childhood influenza vaccination: a critical review". PharmacoEconomics. 30 (8): 647–60. doi:10.2165/11599130-000000000-00000. PMID 22788257. S2CID 38289883.
- Newall AT, Wood JG, Oudin N, MacIntyre CR (February 2010). "Cost-effectiveness of pharmaceutical-based pandemic influenza mitigation strategies". Emerging Infectious Diseases. 16 (2): 224–30. doi:10.3201/eid1602.090571. PMC 2957998. PMID 20113551.
- Lampos V, Yom-Tov E, Pebody R, Cox IJ (2015). "Assessing the impact of a health intervention via user-generated Internet content" (PDF). Data Mining and Knowledge Discovery. 29 (5): 1434–57. doi:10.1007/s10618-015-0427-9. S2CID 215415165. Archived from the original on August 28, 2021. Retrieved August 15, 2022.
- Wagner M, Lampos V, Yom-Tov E, Pebody R, Cox IJ (December 2017). "Estimating the Population Impact of a New Pediatric Influenza Vaccination Program in England Using Social Media Content". Journal of Medical Internet Research. 19 (12): e416. doi:10.2196/jmir.8184. PMC 6257312. PMID 29269339.
- Cho A, Wrammert J (April 2016). "Implications of broadly neutralizing antibodies in the development of a universal influenza vaccine". Current Opinion in Virology. 17: 110–115. doi:10.1016/j.coviro.2016.03.002. PMC 4940123. PMID 27031684.
- Okuno Y, Isegawa Y, Sasao F, Ueda S (May 1993). "A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains". Journal of Virology. 67 (5): 2552–2558. doi:10.1128/JVI.67.5.2552-2558.1993. PMC 237575. PMID 7682624.
- Soema PC, Kompier R, Amorij JP, Kersten GF (August 2015). "Current and next generation influenza vaccines: Formulation and production strategies". European Journal of Pharmaceutics and Biopharmaceutics. 94: 251–263. doi:10.1016/j.ejpb.2015.05.023. hdl:1887/43765. PMID 26047796.
- Deng L, Cho KJ, Fiers W, Saelens X (February 2015). "M2e-Based Universal Influenza A Vaccines". Vaccines. 3 (1): 105–36. doi:10.3390/vaccines3010105. PMC 4494237. PMID 26344949.
- Gottlieb T, Ben-Yedidia T (November 2014). "Epitope-based approaches to a universal influenza vaccine". Journal of Autoimmunity. 54: 15–20. doi:10.1016/j.jaut.2014.07.005. PMID 25172355.
- Toussi DN, Massari P (April 2014). "Immune Adjuvant Effect of Molecularly-defined Toll-Like Receptor Ligands". Vaccines. 2 (2): 323–53. doi:10.3390/vaccines2020323. PMC 4494261. PMID 26344622.
- Jasty M, Bragdon CR, Schutzer S, Rubash H, Haire T, Harris WH (December 1989). "Bone ingrowth into porous coated canine total hip replacements. Quantification by backscattered scanning electron microscopy and image analysis". Scanning Microscopy. 3 (4): 1051–6, discussion 1056–57. doi:10.1016/s1473-3099(15)00252-2. PMID 2633331.
- Liebowitz D, Gottlieb K, Kolhatkar NS, Garg SJ, Asher JM, Nazareno J, et al. (April 2020). "Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study". The Lancet. Infectious Diseases. 20 (4). Elsevier: 435–444. doi:10.1016/S1473-3099(19)30584-5. PMID 31978354. S2CID 210892802.
- Callaway E (May 16, 2022). "Flu vaccine could cut COVID risk". Nature. 605 (7911): 602. Bibcode:2022Natur.605..602C. doi:10.1038/d41586-022-01315-9. PMID 35581411. S2CID 248859545.
- Yen HL, Peiris JS (May 2012). "Virology: bird flu in mammals". Nature. 486 (7403): 332–33. Bibcode:2012Natur.486..332Y. doi:10.1038/nature11192. PMID 22722190. S2CID 205229301.
- Karaca K, Dubovi EJ, Siger L, Robles A, Audonnet JC, Jiansheng Y, et al. (February 2007). "Evaluation of the ability of canarypox-vectored equine influenza virus vaccines to induce humoral immune responses against canine influenza viruses in dogs". American Journal of Veterinary Research. 68 (2): 208–12. doi:10.2460/ajvr.68.2.208. PMID 17269888.

drugs.com

"Influenza Virus Vaccine Inactivated". The American Society of Health-System Pharmacists. November 19, 2018. Archived from the original on October 14, 2019. Retrieved October 13, 2019.

drugtopics.com

Sederstrom J (July 19, 2019). "Researchers Exploring Oral Flu Vaccine and Treatment Options". Drug Topics. Archived from the original on June 8, 2020. Retrieved January 27, 2020.

ecbt.org

"how it's made" (PDF). Archived from the original (PDF) on July 5, 2010.

europa.eu

ecdc.europa.eu

"Implementation of the Council Recommendation on seasonal influenza vaccination (2009/1019/EU)" (PDF). European Centre for Disease Prevention and Control. January 2014. Archived (PDF) from the original on April 10, 2020. Retrieved April 10, 2020.
- Lay summary in: "Implementation of the Council Recommendation on seasonal influenza vaccination". European Centre for Disease Prevention and Control. January 9, 2014.
- Technical Report: Narcolepsy in association with pandemic influenza vaccination (PDF). Stockholm, Sweden: European Centre for Disease Prevention and Control (ECDC). 2012. ISBN 978-92-9193-388-4. Archived from the original (PDF) on December 31, 2013. Retrieved December 30, 2013.
- "Risk groups for severe influenza". European Centre for Disease Prevention and Control (ECDC). October 20, 2017. Archived from the original on October 22, 2019. Retrieved October 22, 2019.
- "ECDC Reviews – New WHO recommendations on seasonal influenza ..." European Centre for Disease Prevention and Control (ECDC). Archived from the original on May 10, 2017. Retrieved December 25, 2016.
- "ECDC Guidance: Priority risk groups for influenza vaccination" (PDF). European Centre for Disease Prevention and Control (ECDC). pp. 7–8. Archived from the original (PDF) on December 25, 2016. Retrieved December 25, 2016.
ema.europa.eu
- "Supemtek EPAR". European Medicines Agency. November 25, 2020. Retrieved June 27, 2024.
- "Fluad Tetra EPAR". European Medicines Agency (EMA). March 24, 2020. Archived from the original on August 1, 2020. Retrieved May 29, 2020.
- "Supemtek EPAR". European Medicines Agency (EMA). September 15, 2020. Archived from the original on January 10, 2021. Retrieved November 27, 2020.
- "Supemtek: Pending EC decision". European Medicines Agency (EMA). September 17, 2020. Archived from the original on September 23, 2020. Retrieved September 21, 2020. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
ec.europa.eu
- "Fluad Tetra Product information". Union Register of medicinal products. Archived from the original on March 5, 2023. Retrieved March 3, 2023.
- "Supemtek Product information". Union Register of medicinal products. Archived from the original on March 5, 2023. Retrieved March 3, 2023.

europeanpharmaceuticalreview.com

Balfour H (June 2, 2021). "First-in-human universal flu vaccine trial begins". European Pharmaceutical Review. Archived from the original on March 29, 2022. Retrieved February 6, 2022. The Phase I trial (NCT04896086) will assess the safety and immunogenicity of the experimental vaccine, FluMos-v1

fao.org

"FAO Recommendations on the Prevention, Control and Eradication of Highly Pathogenic Avian Influenza (HPAI) in Asia" (PDF). Archived (PDF) from the original on February 2, 2010. Retrieved September 16, 2009.

fda.gov

"FDA approves first seasonal influenza vaccine manufactured using cell culture technology" (Press release). U.S. Food and Drug Administration (FDA). Archived from the original on January 2, 2013. This article incorporates text from this source, which is in the public domain.
"FDA approves new seasonal influenza vaccine made using novel technology" (Press release). U.S. Food and Drug Administration (FDA). January 16, 2013. Archived from the original on May 18, 2013. This article incorporates text from this source, which is in the public domain.
"FDA approves first quadrivalent vaccine to prevent seasonal influenza" (Press release). U.S. Food and Drug Administration (FDA). Archived from the original on December 21, 2012. This article incorporates text from this source, which is in the public domain.
"December 14, 2012 Approval Letter – Fluarix Quadrivalent". U.S. Food and Drug Administration (FDA). Archived from the original on January 2, 2013. This article incorporates text from this source, which is in the public domain.
"Fluzone High-Dose Quadrivalent". U.S. Food and Drug Administration (FDA). November 4, 2019. STN: BL 103914. Archived from the original on January 12, 2020. Retrieved February 5, 2020. This article incorporates text from this source, which is in the public domain.
"Fluad Quadrivalent". U.S. Food and Drug Administration (FDA). July 2, 2020. STN: 125510. Archived from the original on August 11, 2020. Retrieved August 25, 2020. This article incorporates text from this source, which is in the public domain.
"Use of Trivalent Influenza Vaccines for the 2024-2025 U.S. flu season". U.S. Food and Drug Administration (FDA). March 5, 2024. Archived from the original on March 7, 2024. Retrieved March 7, 2024. This article incorporates text from this source, which is in the public domain.
"Fluzone High-Dose Quadrivalent". U.S. Food and Drug Administration (FDA). November 14, 2019. Archived from the original on December 1, 2019. Retrieved November 30, 2019. This article incorporates text from this source, which is in the public domain.
"Afluria Quadrivalent". U.S. Food and Drug Administration (FDA). November 8, 2019. Archived from the original on December 1, 2019. Retrieved November 30, 2019. This article incorporates text from this source, which is in the public domain.
"FDA approves first seasonal influenza vaccine containing an adjuvant" (Press release). U.S. Food and Drug Administration (FDA). November 24, 2015. Archived from the original on July 22, 2017. Retrieved August 20, 2017. This article incorporates text from this source, which is in the public domain.
"Fluad". U.S. Food and Drug Administration (FDA). November 8, 2019. STN 125510. Archived from the original on December 2, 2019. Retrieved December 2, 2019. This article incorporates text from this source, which is in the public domain.
"Fluzone, Fluzone High-Dose and Fluzone Intradermal". U.S. Food and Drug Administration (FDA). July 11, 2017. Archived from the original on July 22, 2017. Retrieved June 1, 2020.
Center for Biologics Evaluation and Research. "Approved Products – November 20, 2012 Approval Letter – Flucelvax". U.S. Food and Drug Administration (FDA). Archived from the original on December 3, 2012. This article incorporates text from this source, which is in the public domain.
"Flublok". U.S. Food and Drug Administration (FDA). February 26, 2018. STN 125285. Archived from the original on October 14, 2019. Retrieved October 14, 2019. This article incorporates text from this source, which is in the public domain.
"Flublok Quadrivalent". U.S. Food and Drug Administration (FDA). August 2, 2019. STN 125285. Archived from the original on October 14, 2019. Retrieved October 14, 2019. This article incorporates text from this source, which is in the public domain.
"FDA Approves Vaccines for 2009 H1N1 Influenza Virus" (Press release). September 15, 2009. Archived from the original on October 15, 2009. Retrieved October 15, 2009. This article incorporates text from this source, which is in the public domain.
"Audenz". U.S. Food and Drug Administration (FDA). January 31, 2020. STN: 125692. Archived from the original on August 6, 2020. Retrieved February 5, 2020. This article incorporates text from this source, which is in the public domain.

handle.net

hdl.handle.net

World Health Organization (November 2012). "Vaccines against influenza WHO position paper". Weekly Epidemiological Record. 87 (47): 461–76. hdl:10665/241993. PMID 23210147.
World Health Organization (May 2022). "Vaccines against influenza: WHO position paper – May 2022". Weekly Epidemiological Record. 97 (19): 185–208. hdl:10665/354265.
The immunological basis for immunization series: module 23: influenza vaccines. World Health Organization (WHO). October 2017. hdl:10665/259211. ISBN 978-92-4-151305-0.
Organization WH (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
Organization WH (2021). World Health Organization model list of essential medicines: 22nd list (2021). Geneva: World Health Organization. hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.
Madhi SA, Cutland CL, Kuwanda L, Weinberg A, Hugo A, Jones S, et al. (September 2014). "Influenza vaccination of pregnant women and protection of their infants". The New England Journal of Medicine. 371 (10): 918–31. doi:10.1056/NEJMoa1401480. hdl:2263/42412. PMID 25184864.
Soema PC, Kompier R, Amorij JP, Kersten GF (August 2015). "Current and next generation influenza vaccines: Formulation and production strategies". European Journal of Pharmaceutics and Biopharmaceutics. 94: 251–263. doi:10.1016/j.ejpb.2015.05.023. hdl:1887/43765. PMID 26047796.
Organization WH (2000). WHO Report on Global Surveillance of Epidemic-prone Infectious Diseases – Influenza. World Health Organization (WHO). hdl:10665/66485. WHO/CDS/CSR/ISR/2000/1.

harvard.edu

ui.adsabs.harvard.edu

Landry N, Ward BJ, Trépanier S, Montomoli E, Dargis M, Lapini G, et al. (December 2010). "Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza". PLOS ONE. 5 (12): e15559. Bibcode:2010PLoSO...515559L. doi:10.1371/journal.pone.0015559. PMC 3008737. PMID 21203523.
Callaway E (May 16, 2022). "Flu vaccine could cut COVID risk". Nature. 605 (7911): 602. Bibcode:2022Natur.605..602C. doi:10.1038/d41586-022-01315-9. PMID 35581411. S2CID 248859545.
Yen HL, Peiris JS (May 2012). "Virology: bird flu in mammals". Nature. 486 (7403): 332–33. Bibcode:2012Natur.486..332Y. doi:10.1038/nature11192. PMID 22722190. S2CID 205229301.

haverford.edu

"Swine Flu Epidemics". October 9, 1999. Archived from the original on October 9, 1999.

healio.com

Eamon N. Dreisbach (June 3, 2021). "CDC unable to estimate flu vaccine effectiveness after historically mild season". Healio. Archived from the original on October 8, 2021. Retrieved April 18, 2022.

healthdirect.gov.au

"Flu vaccine FAQs". Healthdirect, Department of Health, Government of Australia. April 1, 2019. Archived from the original on May 29, 2019. Retrieved May 29, 2019.

horsesport.org

"FEI guidelines" (PDF). Archived (PDF) from the original on October 26, 2007.

hpfb-dgpsa.ca

dhpp.hpfb-dgpsa.ca

"Regulatory Decision Summary for Panenza (Haemagglutinin-Strain A (H1N1))". Drug and Health Products Portal. October 27, 2023. Retrieved April 2, 2024.

hres.ca

hpr-rps.hres.ca

"Summary Basis of Decision (SBD) for Supemtek". Health Canada. October 23, 2014. Archived from the original on May 30, 2022. Retrieved May 29, 2022.
"Regulatory Decision Summary - Flucelvax Quad". Health Canada. October 23, 2014. Archived from the original on June 7, 2022. Retrieved June 7, 2022.
"Regulatory Decision Summary - Flucelvax Quad". Health Canada. October 23, 2014. Archived from the original on June 7, 2022. Retrieved June 7, 2022.
"Regulatory Decision Summary - Influvac Tetra". Health Canada. October 23, 2014. Archived from the original on June 7, 2022. Retrieved June 7, 2022.

influenzareport.com

Influenza Report (online book) Archived May 10, 2016, at the Wayback Machine chapter Avian Influenza by Timm C. Harder and Ortrud Werner

knoxnews.com

Brown D (February 18, 2008). "Keeping ahead of flu comes down to guessing game". Knoxville News Sentinel. The Washington Post. Archived from the original on January 11, 2009. Retrieved December 22, 2015.

lohmann-breeders.com

Seemann G, Kock M (2008). "Fertile eggs – a valuable product for vaccine production". Lohmann Breeders. Archived from the original on November 23, 2023. Retrieved October 19, 2023.

medicalnewstoday.com

"First Quadrivalent Vaccine Against Seasonal Flu Wins FDA Approval". March 2, 2012. Archived from the original on March 4, 2012.

nationalhogfarmer.com

"Swine Flu Virus Turns Endemic". September 15, 2007. Archived from the original on April 29, 2009.

nbcnews.com

Tanner L (January 13, 2013). "Hospitals crack down on workers who refuse flu shots". NBC News. Archived from the original on December 3, 2013. Retrieved July 24, 2014.

newsweek.com

Rahman K (October 21, 2021). "Full List of Vaccines Mandated by the U.S. Military". Newsweek. Archived from the original on December 19, 2023.

nhs.uk

"Flu vaccine". UK National Health Service. May 13, 2022. Archived from the original on October 26, 2021. Retrieved August 13, 2022.

nih.gov

pubmed.ncbi.nlm.nih.gov

World Health Organization (November 2012). "Vaccines against influenza WHO position paper". Weekly Epidemiological Record. 87 (47): 461–76. hdl:10665/241993. PMID 23210147.
Manzoli L, Ioannidis JP, Flacco ME, De Vito C, Villari P (July 2012). "Effectiveness and harms of seasonal and pandemic influenza vaccines in children, adults and elderly: a critical review and re-analysis of 15 meta-analyses". Human Vaccines & Immunotherapeutics. 8 (7): 851–62. doi:10.4161/hv.19917. PMC 3495721. PMID 22777099.
Grohskopf LA, Alyanak E, Ferdinands JM, Broder KR, Blanton LH, Talbot HK, et al. (August 2021). "Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season" (PDF). MMWR Recomm Rep. 70 (5): 1–28. doi:10.15585/mmwr.rr7005a1. PMC 8407757. PMID 34448800. Archived (PDF) from the original on August 27, 2021. Retrieved August 29, 2021. This article incorporates text from this source, which is in the public domain.
Institute of Medicine (2005). Knobler SL, Mack A, Mahmoud A, Lemon SM (eds.). The Threat of Pandemic Influenza: Are We Ready? Workshop Summary. The National Academies Press. p. 62. doi:10.17226/11150. ISBN 978-0-309-09504-4. PMID 20669448.
Hampson AW (June 2008). "Vaccines for pandemic influenza. The history of our current vaccines, their limitations and the requirements to deal with a pandemic threat". Annals of the Academy of Medicine, Singapore. 37 (6): 510–17. doi:10.47102/annals-acadmedsg.V37N6p510. PMID 18618064. S2CID 17102174.
Milián E, Kamen AA (2015). "Current and emerging cell culture manufacturing technologies for influenza vaccines". Biomed Res Int. 2015: 504831. doi:10.1155/2015/504831. PMC 4359798. PMID 25815321.
Landry N, Ward BJ, Trépanier S, Montomoli E, Dargis M, Lapini G, et al. (December 2010). "Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza". PLOS ONE. 5 (12): e15559. Bibcode:2010PLoSO...515559L. doi:10.1371/journal.pone.0015559. PMC 3008737. PMID 21203523.
Osterholm MT (May 2005). "Preparing for the next pandemic". The New England Journal of Medicine. 352 (18): 1839–42. CiteSeerX 10.1.1.608.6200. doi:10.1056/NEJMp058068. PMID 15872196. S2CID 45893174.
McCullers JA, Van De Velde LA, Allison KJ, Branum KC, Webby RJ, Flynn PM (June 2010). "Recipients of vaccine against the 1976 "swine flu" have enhanced neutralization responses to the 2009 novel H1N1 influenza virus". Clinical Infectious Diseases. 50 (11): 1487–92. doi:10.1086/652441. PMC 2946351. PMID 20415539.
Koutsakos M, Wheatley AK, Laurie K, Kent SJ, Rockman S (December 2021). "Influenza lineage extinction during the COVID-19 pandemic?". Nature Reviews. Microbiology. 19 (12): 741–742. doi:10.1038/s41579-021-00642-4. PMC 8477979. PMID 34584246.
Osterholm MT, Kelley NS, Sommer A, Belongia EA (January 2012). "Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis". The Lancet. Infectious Diseases. 12 (1): 36–44. doi:10.1016/s1473-3099(11)70295-x. PMID 22032844.
MacIntyre CR, Mahimbo A, Moa AM, Barnes M (December 2016). "Influenza vaccine as a coronary intervention for prevention of myocardial infarction". Heart. 102 (24): 1953–1956. doi:10.1136/heartjnl-2016-309983. PMC 5256393. PMID 27686519.
Centers for Disease Control Prevention (CDC) (August 13, 2004). "Assessment of the effectiveness of the 2003-04 influenza vaccine among children and adults--Colorado, 2003". MMWR. Morbidity and Mortality Weekly Report. 53 (31). Centers for Disease Control and Prevention: 707–710. ISSN 1545-861X. PMID 15306754. Archived from the original on April 27, 2022. Retrieved April 27, 2022. At table.
Centers for Disease Control Prevention (CDC) (January 16, 2004). "Preliminary assessment of the effectiveness of the 2003-04 inactivated influenza vaccine--Colorado, December 2003". MMWR. Morbidity and Mortality Weekly Report. 53 (1). Centers for Disease Control and Prevention: 8–11. ISSN 1545-861X. PMID 14724559. Archived from the original on May 29, 2022. Retrieved April 25, 2022.
Chung JR (March 11, 2022). "Interim Estimates of 2021–22 Seasonal Influenza Vaccine Effectiveness — United States, February 2022". MMWR. Morbidity and Mortality Weekly Report. 71 (10): 365–370. doi:10.15585/mmwr.mm7110a1. ISSN 0149-2195. PMC 8911998. PMID 35271561. Archived from the original on May 16, 2022. Retrieved May 25, 2022.
Fedson DS (1998). "Measuring protection: efficacy versus effectiveness". Developments in Biological Standardization. 95: 195–201. PMID 9855432.
Demicheli V, Jefferson T, Ferroni E, Rivetti A, Di Pietrantonj C (February 2018). "Vaccines for preventing influenza in healthy adults". Cochrane Database of Systematic Reviews. 2020 (2): CD001269. doi:10.1002/14651858.CD001269.pub6. PMC 6491184. PMID 29388196.
Jefferson T (October 2006). "Influenza vaccination: policy versus evidence". BMJ. 333 (7574): 912–15. doi:10.1136/bmj.38995.531701.80. PMC 1626345. PMID 17068038.
Carrat F, Flahault A (September 2007). "Influenza vaccine: the challenge of antigenic drift". Vaccine. 25 (39–40): 6852–6862. doi:10.1016/j.vaccine.2007.07.027. PMID 17719149.
Sautto GA, Kirchenbaum GA, Ross TM (January 19, 2018). "Towards a universal influenza vaccine: different approaches for one goal". Virology Journal. 15 (1): 17. doi:10.1186/s12985-017-0918-y. PMC 5785881. PMID 29370862.
Chow EJ, Doyle JD, Uyeki TM (June 12, 2019). "Influenza virus-related critical illness: prevention, diagnosis, treatment". Critical Care. 23 (1): 214. doi:10.1186/s13054-019-2491-9. PMC 6563376. PMID 31189475.
Krammer F, Smith GJ, Fouchier RA, Peiris M, Kedzierska K, Doherty PC, et al. (June 28, 2018). "Influenza". Nature Reviews Disease Primers. 4 (1): 3. doi:10.1038/s41572-018-0002-y. PMC 7097467. PMID 29955068.
Dabestani NM, Leidner AJ, Seiber EE, Kim H, Graitcer SB, Foppa IM, et al. (September 2019). "A review of the cost-effectiveness of adult influenza vaccination and other preventive services". Preventive Medicine. 126: 105734. doi:10.1016/j.ypmed.2019.05.022. PMC 6778688. PMID 31152830.
Ghebrehewet S, MacPherson P, Ho A (December 7, 2016). "Influenza". The BMJ. 355: i6258. doi:10.1136/bmj.i6258. PMC 5141587. PMID 27927672.
Principi N, Esposito S (March 4, 2018). "Protection of children against influenza: Emerging problems". Human Vaccines & Immunotherapeutics. 14 (3): 750–757. doi:10.1080/21645515.2017.1279772. PMC 5861800. PMID 28129049.
Thompson MG, Pierse N, Huang QS, Prasad N, Duque J, Newbern EC, et al. (September 18, 2018). "Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012–2015". Vaccine. 36 (39): 5916–5925. doi:10.1016/j.vaccine.2018.07.028. ISSN 0264-410X. PMID 30077480. S2CID 51922011. Archived from the original on May 27, 2022. Retrieved April 23, 2022.
Tenforde MW, Talbot HK, Trabue CH, Gaglani M, McNeal TS, Monto AS, et al. (December 30, 2020). "Influenza Vaccine Effectiveness Against Hospitalization in the United States, 2019–2020". The Journal of Infectious Diseases. 224 (5): 813–820. doi:10.1093/infdis/jiaa800. ISSN 0022-1899. PMC 8408767. PMID 33378531. Archived from the original on April 23, 2022. Retrieved April 23, 2022.
Ferdinands JM, Thompson MG, Blanton L, Spencer S, Grant L, Fry AM (June 23, 2021). "Does influenza vaccination attenuate the severity of breakthrough infections? A narrative review and recommendations for further research". Vaccine. 39 (28): 3678–3695. doi:10.1016/j.vaccine.2021.05.011. ISSN 0264-410X. PMID 34090700. S2CID 235361401. Archived from the original on April 23, 2022. Retrieved April 23, 2022.
Ramsay LC, Buchan SA, Stirling RG, Cowling BJ, Feng S, Kwong JC, et al. (January 2019). "The impact of repeated vaccination on influenza vaccine effectiveness: a systematic review and meta-analysis". BMC Med. 17 (1): 9. doi:10.1186/s12916-018-1239-8. PMC 6327561. PMID 30626399.
Belongia EA, Skowronski DM, McLean HQ, Chambers C, Sundaram ME, De Serres G (July 2017). "Repeated annual influenza vaccination and vaccine effectiveness: review of evidence". Expert Rev Vaccines. 16 (7): 723–36. doi:10.1080/14760584.2017.1334554. PMID 28562111.
Gemmill I, Young K (June 7, 2018). "Summary of the NACI literature review on the comparative effectiveness of subunit and split virus inactivated influenza vaccines in older adults". Canada Communicable Disease Report. 44 (6): 129–133. doi:10.14745/ccdr.v44i06a02. ISSN 1481-8531. PMC 6449119. PMID 31015805. Archived from the original on May 17, 2020. Retrieved June 2, 2020.
MacIntyre CR, Mahimbo A, Moa AM, Barnes M (December 2016). "Influenza vaccine as a coronary intervention for prevention of myocardial infarction". Heart. 102 (24): 1953–1956. doi:10.1136/heartjnl-2016-309983. PMC 5256393. PMID 27686519.
Jefferson T, Rivetti A, Di Pietrantonj C, Demicheli V (February 2018). "Vaccines for preventing influenza in healthy children". Cochrane Database of Systematic Reviews. 2018 (2): CD004879. doi:10.1002/14651858.CD004879.pub5. PMC 6491174. PMID 29388195.
Peleg N, Zevit N, Shamir R, Chodick G, Levy I (January 2015). "Seasonal influenza vaccination rates and reasons for non-vaccination in children with gastrointestinal disorders". Vaccine. 33 (1): 182–186. doi:10.1016/j.vaccine.2014.10.086. PMID 25444802.
Osterholm MT, Kelley NS, Sommer A, Belongia EA (January 2012). "Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis". The Lancet. Infectious Diseases. 12 (1): 36–44. doi:10.1016/S1473-3099(11)70295-X. PMID 22032844.
Burls A, Jordan R, Barton P, Olowokure B, Wake B, Albon E, et al. (May 2006). "Vaccinating healthcare workers against influenza to protect the vulnerable – is it a good use of healthcare resources? A systematic review of the evidence and an economic evaluation". Vaccine. 24 (19): 4212–21. doi:10.1016/j.vaccine.2005.12.043. PMID 16546308.
Ahmed F, Lindley MC, Allred N, Weinbaum CM, Grohskopf L (January 2014). "Effect of influenza vaccination of healthcare personnel on morbidity and mortality among patients: systematic review and grading of evidence". Clinical Infectious Diseases. 58 (1): 50–57. doi:10.1093/cid/cit580. PMID 24046301.
Griffin MR (January 2014). "Influenza vaccination of healthcare workers: making the grade for action". Clinical Infectious Diseases. 58 (1): 58–60. doi:10.1093/cid/cit590. PMID 24046312.
Simonsen L, Viboud C, Taylor RJ, Miller MA, Jackson L (October 2009). "Influenza vaccination and mortality benefits: new insights, new opportunities". Vaccine. 27 (45): 6300–04. doi:10.1016/j.vaccine.2009.07.008. PMID 19840664.
Demicheli V, Jefferson T, Di Pietrantonj C, Ferroni E, Thorning S, Thomas RE, et al. (February 2018). "Vaccines for preventing influenza in the elderly". Cochrane Database of Systematic Reviews. 2 (11): CD004876. doi:10.1002/14651858.CD004876.pub4. PMC 6491101. PMID 29388197.
Darvishian M, Bijlsma MJ, Hak E, van den Heuvel ER (December 2014). "Effectiveness of seasonal influenza vaccine in community-dwelling elderly people: a meta-analysis of test-negative design case-control studies". The Lancet. Infectious Diseases. 14 (12): 1228–39. doi:10.1016/S1473-3099(14)70960-0. PMID 25455990.
Nichol KL, Nordin JD, Nelson DB, Mullooly JP, Hak E (October 2007). "Effectiveness of influenza vaccine in the community-dwelling elderly". The New England Journal of Medicine. 357 (14): 1373–81. doi:10.1056/NEJMoa070844. PMID 17914038. S2CID 14850833.
Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA (October 2007). "Mortality benefits of influenza vaccination in elderly people: an ongoing controversy". The Lancet. Infectious Diseases. 7 (10): 658–66. doi:10.1016/S1473-3099(07)70236-0. PMID 17897608.
Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, et al. (January 2003). "Mortality associated with influenza and respiratory syncytial virus in the United States". JAMA. 289 (2): 179–86. doi:10.1001/jama.289.2.179. PMID 12517228. S2CID 5018362.
DiazGranados CA, Dunning AJ, Kimmel M, Kirby D, Treanor J, Collins A, et al. (August 2014). "Efficacy of high-dose versus standard-dose influenza vaccine in older adults". The New England Journal of Medicine. 371 (7): 635–45. doi:10.1056/NEJMoa1315727. PMID 25119609. S2CID 205096393.
Wells C, Grobelna A (January 8, 2019). "High Dose Influenza Vaccine for Adults: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines" (PDF). Rapid Response Report. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). ISSN 1922-8147. PMID 31141324. Archived (PDF) from the original on August 1, 2020. Retrieved August 15, 2022.
Mascagni P, Vicenzi E, Kajaste-Rudnitski A, Pellicciotta G, Monti A, Cervi C, et al. (2012). "Assessment of efficacy and safety of pandemic A/H1N1/2009 influenza vaccine in a group of health care workers". La Medicina del Lavoro. 103 (3): 220–29. PMID 22838300.
"Influenza vaccine with squalene adjuvant: new preparation. No better than available products". Prescrire International. 13 (74): 206–08. December 2004. PMID 15599987.
Camilloni B, Basileo M, Valente S, Nunzi E, Iorio AM (2015). "Immunogenicity of intramuscular MF59-adjuvanted and intradermal administered influenza enhanced vaccines in subjects aged over 60: A literature review". Human Vaccines & Immunotherapeutics. 11 (3): 553–63. doi:10.1080/21645515.2015.1011562. PMC 4514405. PMID 25714138.
- Lay summary in: "Literature Review Update on the Efficacy and Effectiveness of High-Dose (Fluzone High-Dose) and MF59-Adjuvanted (Fluad) Trivalent Inactivated Influenza Vaccines in Adults 65 Years of Age and Older". Public Health Agency of Canada. May 1, 2018.
- Van Damme P, Arnou R, Kafeja F, Fiquet A, Richard P, Thomas S, et al. (May 2010). "Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study". BMC Infectious Diseases. 10: 134. doi:10.1186/1471-2334-10-134. PMC 2895601. PMID 20504306.
- Haverkate M, D'Ancona F, Giambi C, Johansen K, Lopalco PL, Cozza V, et al. (VENICE project gatekeepers contact points collective) (May 2012). "Mandatory and recommended vaccination in the EU, Iceland and Norway: results of the VENICE 2010 survey on the ways of implementing national vaccination programmes". Euro Surveillance. 17 (22). doi:10.2807/ese.17.22.20183-en. PMID 22687916.
- Field RI (November 2009). "Mandatory vaccination of health care workers: whose rights should come first?". P & T. 34 (11): 615–18. PMC 2810172. PMID 20140133.
- Kassianos G (2015). "Willingness of European healthcare workers to undergo vaccination against seasonal influenza: current situation and suggestions for improvement". Drugs in Context. 4: 212268. doi:10.7573/dic.212268. PMC 4316812. PMID 25657810.
- Thomas RE, Jefferson T, Lasserson TJ (June 2016). "Influenza vaccination for healthcare workers who care for people aged 60 or older living in long-term care institutions". The Cochrane Database of Systematic Reviews. 2016 (6): CD005187. doi:10.1002/14651858.CD005187.pub5. PMC 8504984. PMID 27251461.
- Fell DB, Sprague AE, Liu N, Yasseen AS, Wen SW, Smith G, et al. (June 2012). "H1N1 influenza vaccination during pregnancy and fetal and neonatal outcomes". American Journal of Public Health (Submitted manuscript). 102 (6): e33–40. doi:10.2105/AJPH.2011.300606. PMC 3483960. PMID 22515877.
- Madhi SA, Cutland CL, Kuwanda L, Weinberg A, Hugo A, Jones S, et al. (September 2014). "Influenza vaccination of pregnant women and protection of their infants". The New England Journal of Medicine. 371 (10): 918–31. doi:10.1056/NEJMoa1401480. hdl:2263/42412. PMID 25184864.
- Haber P, Sejvar J, Mikaeloff Y, DeStefano F (2009). "Vaccines and Guillain-Barré syndrome". Drug Safety. 32 (4): 309–23. doi:10.2165/00002018-200932040-00005. PMID 19388722. S2CID 33670594.
- "Reorganized text". JAMA Otolaryngology–Head & Neck Surgery. 141 (5): 428. May 2015. doi:10.1001/jamaoto.2015.0540. PMID 25996397. S2CID 26612829.
- Stowe J, Andrews N, Wise L, Miller E (February 2009). "Investigation of the temporal association of Guillain-Barre syndrome with influenza vaccine and influenza-like illness using the United Kingdom General Practice Research Database". American Journal of Epidemiology. 169 (3): 382–88. doi:10.1093/aje/kwn310. PMID 19033158.
- Sivadon-Tardy V, Orlikowski D, Porcher R, Sharshar T, Durand MC, Enouf V, et al. (January 2009). "Guillain-Barré syndrome and influenza virus infection". Clinical Infectious Diseases. 48 (1): 48–56. doi:10.1086/594124. PMID 19025491.
- Vellozzi C, Burwen DR, Dobardzic A, Ball R, Walton K, Haber P (March 2009). "Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring". Vaccine. 27 (15): 2114–20. doi:10.1016/j.vaccine.2009.01.125. PMID 19356614. Archived from the original on August 1, 2020. Retrieved May 21, 2020.
- Turner PJ, Southern J, Andrews NJ, Miller E, Erlewyn-Lajeunesse M (December 2015). "Safety of live attenuated influenza vaccine in young people with egg allergy: multicentre prospective cohort study". BMJ. 351: h6291. doi:10.1136/bmj.h6291. PMC 4673102. PMID 26645895.
- Greenhawt M (December 2015). "Live attenuated influenza vaccine for children with egg allergy". BMJ. 351: h6656. doi:10.1136/bmj.h6656. PMID 26657778. S2CID 37037904.
- Offit PA (September 2007). "Thimerosal and vaccines – a cautionary tale". The New England Journal of Medicine. 357 (13): 1278–79. doi:10.1056/NEJMp078187. PMID 17898096. S2CID 36318722.
- To KW, Lai A, Lee KC, Koh D, Lee SS (October 2016). "Increasing the coverage of influenza vaccination in healthcare workers: review of challenges and solutions". The Journal of Hospital Infection. 94 (2): 133–42. doi:10.1016/j.jhin.2016.07.003. PMID 27546456.
- Rubin GJ, Potts HW, Michie S (March 2011). "Likely uptake of swine and seasonal flu vaccines among healthcare workers. A cross-sectional analysis of UK telephone survey data". Vaccine. 29 (13): 2421–28. doi:10.1016/j.vaccine.2011.01.035. PMID 21277402.
- Couch RB, Winokur P, Brady R, Belshe R, Chen WH, Cate TR, et al. (November 2007). "Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects". Vaccine. 25 (44): 7656–63. doi:10.1016/j.vaccine.2007.08.042. PMC 2243220. PMID 17913310.
- Lee JK, Lam GK, Shin T, Kim J, Krishnan A, Greenberg DP, et al. (May 2018). "Efficacy and effectiveness of high-dose versus standard-dose influenza vaccination for older adults: a systematic review and meta-analysis". Expert Rev Vaccines. 17 (5): 435–443. doi:10.1080/14760584.2018.1471989. PMID 29715054. S2CID 21688517.
- Robertson CA, DiazGranados CA, Decker MD, Chit A, Mercer M, Greenberg DP (December 2016). "Fluzone High-Dose Influenza Vaccine". Expert Rev Vaccines. 15 (12): 1495–1505. doi:10.1080/14760584.2016.1254044. PMID 27813430.
- Centers for Disease Control Prevention (CDC) (December 2010). "Seasonal influenza and 2009 H1N1 influenza vaccination coverage among pregnant women – 10 states, 2009–10 influenza season" (PDF). Morbidity and Mortality Weekly Report (MMWR). 59 (47): 1541–45. PMID 21124293. Archived (PDF) from the original on June 25, 2017. This article incorporates text from this source, which is in the public domain.
- Han YK, Michie S, Potts HW, Rubin GJ (March 2016). "Predictors of influenza vaccine uptake during the 2009/10 influenza A H1N1v ('swine flu') pandemic: Results from five national surveys in the United Kingdom". Preventive Medicine. 84: 57–61. doi:10.1016/j.ypmed.2015.12.018. PMC 4766366. PMID 26757401.
- Bish A, Yardley L, Nicoll A, Michie S (September 2011). "Factors associated with uptake of vaccination against pandemic influenza: a systematic review". Vaccine. 29 (38): 6472–84. doi:10.1016/j.vaccine.2011.06.107. PMID 21756960.
- Brien S, Kwong JC, Buckeridge DL (February 2012). "The determinants of 2009 pandemic A/H1N1 influenza vaccination: a systematic review". Vaccine. 30 (7): 1255–64. doi:10.1016/j.vaccine.2011.12.089. PMID 22214889.
- Thomas RE, Lorenzetti DL (May 2018). "Interventions to increase influenza vaccination rates of those 60 years and older in the community". The Cochrane Database of Systematic Reviews. 5 (5): CD005188. doi:10.1002/14651858.CD005188.pub4. PMC 6494593. PMID 29845606.
- Centers for Disease Control Prevention (CDC) (October 2009). "Update on influenza A (H1N1) 2009 monovalent vaccines" (PDF). Morbidity and Mortality Weekly Report (MMWR). 58 (39): 1100–01. PMID 19816398. Archived (PDF) from the original on June 29, 2011. This article incorporates text from this source, which is in the public domain.
- La Torre G, Di Thiene D, Cadeddu C, Ricciardi W, Boccia A (December 2009). "Behaviours regarding preventive measures against pandemic H1N1 influenza among Italian healthcare workers, October 2009". Euro Surveillance. 14 (49). PMID 20003908.
- Amodio E, Anastasi G, Marsala MG, Torregrossa MV, Romano N, Firenze A (February 2011). "Vaccination against the 2009 pandemic influenza A (H1N1) among healthcare workers in the major teaching hospital of Sicily (Italy)". Vaccine. 29 (7): 1408–12. doi:10.1016/j.vaccine.2010.12.041. PMID 21199700.
- Chor JS, Ngai KL, Goggins WB, Wong MC, Wong SY, Lee N, et al. (August 2009). "Willingness of Hong Kong healthcare workers to accept pre-pandemic influenza vaccination at different WHO alert levels: two questionnaire surveys". BMJ. 339: b3391. doi:10.1136/bmj.b3391. PMC 2731837. PMID 19706937.
- Centers for Disease Control Prevention (CDC) (August 2011). "Influenza vaccination coverage among health-care personnel – United States, 2010–11 influenza season" (PDF). Morbidity and Mortality Weekly Report (MMWR). 60 (32): 1073–77. PMID 21849963. Archived (PDF) from the original on May 25, 2017. This article incorporates text from this source, which is in the public domain.
- Centers for Disease Control Prevention (CDC) (September 2012). "Influenza vaccination coverage among health-care personnel: 2011–12 influenza season, United States" (PDF). Morbidity and Mortality Weekly Report (MMWR). 61: 753–57. PMID 23013720. Archived (PDF) from the original on June 24, 2017. This article incorporates text from this source, which is in the public domain.
- Bull AL, Bennett N, Pitcher HC, Russo PL, Richards MJ (February 2007). "Influenza vaccine coverage among health care workers in Victorian public hospitals". The Medical Journal of Australia. 186 (4): 185–86. doi:10.5694/j.1326-5377.2007.tb00858.x. PMID 17309419. S2CID 25091208.
- Abbasi J (November 2019). "The Search for a Universal Flu Vaccine Heats Up". JAMA. 322 (20): 1942–1944. doi:10.1001/jama.2019.16816. PMID 31693060. S2CID 207903441.
- Nachbagauer R, Krammer F (April 2017). "Universal influenza virus vaccines and therapeutic antibodies". Clinical Microbiology and Infection. 23 (4): 222–228. doi:10.1016/j.cmi.2017.02.009. PMC 5389886. PMID 28216325.
- Bernstein DI, Guptill J, Naficy A, Nachbagauer R, Berlanda-Scorza F, Feser J, et al. (January 2020). "Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial". The Lancet. Infectious Diseases. 20 (1): 80–91. doi:10.1016/S1473-3099(19)30393-7. PMC 6928577. PMID 31630990.
- Nachbagauer R, Feser J, Naficy A, Bernstein DI, Guptill J, Walter EB, et al. (January 2021). "A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial". Nature Medicine. 27 (1): 106–114. doi:10.1038/s41591-020-1118-7. PMID 33288923.
- Bright RA, Carter DM, Daniluk S, Toapanta FR, Ahmad A, Gavrilov V, et al. (May 2007). "Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin". Vaccine. 25 (19): 3871–78. doi:10.1016/j.vaccine.2007.01.106. PMID 17337102.
- Sparrow E, Wood JG, Chadwick C, Newall AT, Torvaldsen S, Moen A, et al. (January 2021). "Global production capacity of seasonal and pandemic influenza vaccines in 2019". Vaccine. 39 (3): 512–520. doi:10.1016/j.vaccine.2020.12.018. PMC 7814984. PMID 33341308.
- Jit M, Newall AT, Beutels P (April 2013). "Key issues for estimating the impact and cost-effectiveness of seasonal influenza vaccination strategies". Human Vaccines & Immunotherapeutics. 9 (4): 834–40. doi:10.4161/hv.23637. PMC 3903903. PMID 23357859.
- Postma MJ, Baltussen RP, Palache AM, Wilschut JC (April 2006). "Further evidence for favorable cost-effectiveness of elderly influenza vaccination". Expert Review of Pharmacoeconomics & Outcomes Research. 6 (2): 215–27. doi:10.1586/14737167.6.2.215. PMID 20528557. S2CID 12765724.
- Newall AT, Kelly H, Harsley S, Scuffham PA (2009). "Cost effectiveness of influenza vaccination in older adults: a critical review of economic evaluations for the 50- to 64-year age group". PharmacoEconomics. 27 (6): 439–50. doi:10.2165/00019053-200927060-00001. PMID 19640008. S2CID 20855671.
- Newall AT, Viboud C, Wood JG (June 2010). "Influenza-attributable mortality in Australians aged more than 50 years: a comparison of different modelling approaches". Epidemiology and Infection. 138 (6): 836–42. doi:10.1017/S095026880999118X. PMID 19941685. S2CID 29939376.
- Newall AT, Dehollain JP, Creighton P, Beutels P, Wood JG (August 2013). "Understanding the cost-effectiveness of influenza vaccination in children: methodological choices and seasonal variability". PharmacoEconomics. 31 (8): 693–702. doi:10.1007/s40273-013-0060-7. PMID 23645539. S2CID 8616720.
- Newall AT, Scuffham PA (December 2011). "Uncertainty and variability in influenza cost-effectiveness models". Australian and New Zealand Journal of Public Health. 35 (6): 576, author reply 576–77. doi:10.1111/j.1753-6405.2011.00788.x. PMID 22151168. S2CID 22402257.
- Gatwood J, Meltzer MI, Messonnier M, Ortega-Sanchez IR, Balkrishnan R, Prosser LA (January 2012). "Seasonal influenza vaccination of healthy working-age adults: a review of economic evaluations". Drugs. 72 (1): 35–48. doi:10.2165/11597310-000000000-00000. PMID 22191794. S2CID 46305863.
- Newall AT, Jit M, Beutels P (August 2012). "Economic evaluations of childhood influenza vaccination: a critical review". PharmacoEconomics. 30 (8): 647–60. doi:10.2165/11599130-000000000-00000. PMID 22788257. S2CID 38289883.
- Newall AT, Wood JG, Oudin N, MacIntyre CR (February 2010). "Cost-effectiveness of pharmaceutical-based pandemic influenza mitigation strategies". Emerging Infectious Diseases. 16 (2): 224–30. doi:10.3201/eid1602.090571. PMC 2957998. PMID 20113551.
- Wagner M, Lampos V, Yom-Tov E, Pebody R, Cox IJ (December 2017). "Estimating the Population Impact of a New Pediatric Influenza Vaccination Program in England Using Social Media Content". Journal of Medical Internet Research. 19 (12): e416. doi:10.2196/jmir.8184. PMC 6257312. PMID 29269339.
- Cho A, Wrammert J (April 2016). "Implications of broadly neutralizing antibodies in the development of a universal influenza vaccine". Current Opinion in Virology. 17: 110–115. doi:10.1016/j.coviro.2016.03.002. PMC 4940123. PMID 27031684.
- Okuno Y, Isegawa Y, Sasao F, Ueda S (May 1993). "A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains". Journal of Virology. 67 (5): 2552–2558. doi:10.1128/JVI.67.5.2552-2558.1993. PMC 237575. PMID 7682624.
- Soema PC, Kompier R, Amorij JP, Kersten GF (August 2015). "Current and next generation influenza vaccines: Formulation and production strategies". European Journal of Pharmaceutics and Biopharmaceutics. 94: 251–263. doi:10.1016/j.ejpb.2015.05.023. hdl:1887/43765. PMID 26047796.
- Deng L, Cho KJ, Fiers W, Saelens X (February 2015). "M2e-Based Universal Influenza A Vaccines". Vaccines. 3 (1): 105–36. doi:10.3390/vaccines3010105. PMC 4494237. PMID 26344949.
- Gottlieb T, Ben-Yedidia T (November 2014). "Epitope-based approaches to a universal influenza vaccine". Journal of Autoimmunity. 54: 15–20. doi:10.1016/j.jaut.2014.07.005. PMID 25172355.
- Toussi DN, Massari P (April 2014). "Immune Adjuvant Effect of Molecularly-defined Toll-Like Receptor Ligands". Vaccines. 2 (2): 323–53. doi:10.3390/vaccines2020323. PMC 4494261. PMID 26344622.
- Jasty M, Bragdon CR, Schutzer S, Rubash H, Haire T, Harris WH (December 1989). "Bone ingrowth into porous coated canine total hip replacements. Quantification by backscattered scanning electron microscopy and image analysis". Scanning Microscopy. 3 (4): 1051–6, discussion 1056–57. doi:10.1016/s1473-3099(15)00252-2. PMID 2633331.
- Liebowitz D, Gottlieb K, Kolhatkar NS, Garg SJ, Asher JM, Nazareno J, et al. (April 2020). "Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study". The Lancet. Infectious Diseases. 20 (4). Elsevier: 435–444. doi:10.1016/S1473-3099(19)30584-5. PMID 31978354. S2CID 210892802.
- Callaway E (May 16, 2022). "Flu vaccine could cut COVID risk". Nature. 605 (7911): 602. Bibcode:2022Natur.605..602C. doi:10.1038/d41586-022-01315-9. PMID 35581411. S2CID 248859545.
- Yen HL, Peiris JS (May 2012). "Virology: bird flu in mammals". Nature. 486 (7403): 332–33. Bibcode:2012Natur.486..332Y. doi:10.1038/nature11192. PMID 22722190. S2CID 205229301.
- Karaca K, Dubovi EJ, Siger L, Robles A, Audonnet JC, Jiansheng Y, et al. (February 2007). "Evaluation of the ability of canarypox-vectored equine influenza virus vaccines to induce humoral immune responses against canine influenza viruses in dogs". American Journal of Veterinary Research. 68 (2): 208–12. doi:10.2460/ajvr.68.2.208. PMID 17269888.
ncbi.nlm.nih.gov
- Manzoli L, Ioannidis JP, Flacco ME, De Vito C, Villari P (July 2012). "Effectiveness and harms of seasonal and pandemic influenza vaccines in children, adults and elderly: a critical review and re-analysis of 15 meta-analyses". Human Vaccines & Immunotherapeutics. 8 (7): 851–62. doi:10.4161/hv.19917. PMC 3495721. PMID 22777099.
- Grohskopf LA, Alyanak E, Ferdinands JM, Broder KR, Blanton LH, Talbot HK, et al. (August 2021). "Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season" (PDF). MMWR Recomm Rep. 70 (5): 1–28. doi:10.15585/mmwr.rr7005a1. PMC 8407757. PMID 34448800. Archived (PDF) from the original on August 27, 2021. Retrieved August 29, 2021. This article incorporates text from this source, which is in the public domain.
- Milián E, Kamen AA (2015). "Current and emerging cell culture manufacturing technologies for influenza vaccines". Biomed Res Int. 2015: 504831. doi:10.1155/2015/504831. PMC 4359798. PMID 25815321.
- Landry N, Ward BJ, Trépanier S, Montomoli E, Dargis M, Lapini G, et al. (December 2010). "Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza". PLOS ONE. 5 (12): e15559. Bibcode:2010PLoSO...515559L. doi:10.1371/journal.pone.0015559. PMC 3008737. PMID 21203523.
- McCullers JA, Van De Velde LA, Allison KJ, Branum KC, Webby RJ, Flynn PM (June 2010). "Recipients of vaccine against the 1976 "swine flu" have enhanced neutralization responses to the 2009 novel H1N1 influenza virus". Clinical Infectious Diseases. 50 (11): 1487–92. doi:10.1086/652441. PMC 2946351. PMID 20415539.
- Koutsakos M, Wheatley AK, Laurie K, Kent SJ, Rockman S (December 2021). "Influenza lineage extinction during the COVID-19 pandemic?". Nature Reviews. Microbiology. 19 (12): 741–742. doi:10.1038/s41579-021-00642-4. PMC 8477979. PMID 34584246.
- MacIntyre CR, Mahimbo A, Moa AM, Barnes M (December 2016). "Influenza vaccine as a coronary intervention for prevention of myocardial infarction". Heart. 102 (24): 1953–1956. doi:10.1136/heartjnl-2016-309983. PMC 5256393. PMID 27686519.
- Chung JR (March 11, 2022). "Interim Estimates of 2021–22 Seasonal Influenza Vaccine Effectiveness — United States, February 2022". MMWR. Morbidity and Mortality Weekly Report. 71 (10): 365–370. doi:10.15585/mmwr.mm7110a1. ISSN 0149-2195. PMC 8911998. PMID 35271561. Archived from the original on May 16, 2022. Retrieved May 25, 2022.
- Demicheli V, Jefferson T, Ferroni E, Rivetti A, Di Pietrantonj C (February 2018). "Vaccines for preventing influenza in healthy adults". Cochrane Database of Systematic Reviews. 2020 (2): CD001269. doi:10.1002/14651858.CD001269.pub6. PMC 6491184. PMID 29388196.
- Jefferson T (October 2006). "Influenza vaccination: policy versus evidence". BMJ. 333 (7574): 912–15. doi:10.1136/bmj.38995.531701.80. PMC 1626345. PMID 17068038.
- Sautto GA, Kirchenbaum GA, Ross TM (January 19, 2018). "Towards a universal influenza vaccine: different approaches for one goal". Virology Journal. 15 (1): 17. doi:10.1186/s12985-017-0918-y. PMC 5785881. PMID 29370862.
- Chow EJ, Doyle JD, Uyeki TM (June 12, 2019). "Influenza virus-related critical illness: prevention, diagnosis, treatment". Critical Care. 23 (1): 214. doi:10.1186/s13054-019-2491-9. PMC 6563376. PMID 31189475.
- Krammer F, Smith GJ, Fouchier RA, Peiris M, Kedzierska K, Doherty PC, et al. (June 28, 2018). "Influenza". Nature Reviews Disease Primers. 4 (1): 3. doi:10.1038/s41572-018-0002-y. PMC 7097467. PMID 29955068.
- Dabestani NM, Leidner AJ, Seiber EE, Kim H, Graitcer SB, Foppa IM, et al. (September 2019). "A review of the cost-effectiveness of adult influenza vaccination and other preventive services". Preventive Medicine. 126: 105734. doi:10.1016/j.ypmed.2019.05.022. PMC 6778688. PMID 31152830.
- Ghebrehewet S, MacPherson P, Ho A (December 7, 2016). "Influenza". The BMJ. 355: i6258. doi:10.1136/bmj.i6258. PMC 5141587. PMID 27927672.
- Principi N, Esposito S (March 4, 2018). "Protection of children against influenza: Emerging problems". Human Vaccines & Immunotherapeutics. 14 (3): 750–757. doi:10.1080/21645515.2017.1279772. PMC 5861800. PMID 28129049.
- Tenforde MW, Talbot HK, Trabue CH, Gaglani M, McNeal TS, Monto AS, et al. (December 30, 2020). "Influenza Vaccine Effectiveness Against Hospitalization in the United States, 2019–2020". The Journal of Infectious Diseases. 224 (5): 813–820. doi:10.1093/infdis/jiaa800. ISSN 0022-1899. PMC 8408767. PMID 33378531. Archived from the original on April 23, 2022. Retrieved April 23, 2022.
- Ramsay LC, Buchan SA, Stirling RG, Cowling BJ, Feng S, Kwong JC, et al. (January 2019). "The impact of repeated vaccination on influenza vaccine effectiveness: a systematic review and meta-analysis". BMC Med. 17 (1): 9. doi:10.1186/s12916-018-1239-8. PMC 6327561. PMID 30626399.
- Gemmill I, Young K (June 7, 2018). "Summary of the NACI literature review on the comparative effectiveness of subunit and split virus inactivated influenza vaccines in older adults". Canada Communicable Disease Report. 44 (6): 129–133. doi:10.14745/ccdr.v44i06a02. ISSN 1481-8531. PMC 6449119. PMID 31015805. Archived from the original on May 17, 2020. Retrieved June 2, 2020.
- MacIntyre CR, Mahimbo A, Moa AM, Barnes M (December 2016). "Influenza vaccine as a coronary intervention for prevention of myocardial infarction". Heart. 102 (24): 1953–1956. doi:10.1136/heartjnl-2016-309983. PMC 5256393. PMID 27686519.
- Jefferson T, Rivetti A, Di Pietrantonj C, Demicheli V (February 2018). "Vaccines for preventing influenza in healthy children". Cochrane Database of Systematic Reviews. 2018 (2): CD004879. doi:10.1002/14651858.CD004879.pub5. PMC 6491174. PMID 29388195.
- Demicheli V, Jefferson T, Di Pietrantonj C, Ferroni E, Thorning S, Thomas RE, et al. (February 2018). "Vaccines for preventing influenza in the elderly". Cochrane Database of Systematic Reviews. 2 (11): CD004876. doi:10.1002/14651858.CD004876.pub4. PMC 6491101. PMID 29388197.
- Camilloni B, Basileo M, Valente S, Nunzi E, Iorio AM (2015). "Immunogenicity of intramuscular MF59-adjuvanted and intradermal administered influenza enhanced vaccines in subjects aged over 60: A literature review". Human Vaccines & Immunotherapeutics. 11 (3): 553–63. doi:10.1080/21645515.2015.1011562. PMC 4514405. PMID 25714138.
  - Lay summary in: "Literature Review Update on the Efficacy and Effectiveness of High-Dose (Fluzone High-Dose) and MF59-Adjuvanted (Fluad) Trivalent Inactivated Influenza Vaccines in Adults 65 Years of Age and Older". Public Health Agency of Canada. May 1, 2018.
  - Van Damme P, Arnou R, Kafeja F, Fiquet A, Richard P, Thomas S, et al. (May 2010). "Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study". BMC Infectious Diseases. 10: 134. doi:10.1186/1471-2334-10-134. PMC 2895601. PMID 20504306.
  - Field RI (November 2009). "Mandatory vaccination of health care workers: whose rights should come first?". P & T. 34 (11): 615–18. PMC 2810172. PMID 20140133.
  - Kassianos G (2015). "Willingness of European healthcare workers to undergo vaccination against seasonal influenza: current situation and suggestions for improvement". Drugs in Context. 4: 212268. doi:10.7573/dic.212268. PMC 4316812. PMID 25657810.
  - Thomas RE, Jefferson T, Lasserson TJ (June 2016). "Influenza vaccination for healthcare workers who care for people aged 60 or older living in long-term care institutions". The Cochrane Database of Systematic Reviews. 2016 (6): CD005187. doi:10.1002/14651858.CD005187.pub5. PMC 8504984. PMID 27251461.
  - Fell DB, Sprague AE, Liu N, Yasseen AS, Wen SW, Smith G, et al. (June 2012). "H1N1 influenza vaccination during pregnancy and fetal and neonatal outcomes". American Journal of Public Health (Submitted manuscript). 102 (6): e33–40. doi:10.2105/AJPH.2011.300606. PMC 3483960. PMID 22515877.
  - Turner PJ, Southern J, Andrews NJ, Miller E, Erlewyn-Lajeunesse M (December 2015). "Safety of live attenuated influenza vaccine in young people with egg allergy: multicentre prospective cohort study". BMJ. 351: h6291. doi:10.1136/bmj.h6291. PMC 4673102. PMID 26645895.
  - Couch RB, Winokur P, Brady R, Belshe R, Chen WH, Cate TR, et al. (November 2007). "Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects". Vaccine. 25 (44): 7656–63. doi:10.1016/j.vaccine.2007.08.042. PMC 2243220. PMID 17913310.
  - Han YK, Michie S, Potts HW, Rubin GJ (March 2016). "Predictors of influenza vaccine uptake during the 2009/10 influenza A H1N1v ('swine flu') pandemic: Results from five national surveys in the United Kingdom". Preventive Medicine. 84: 57–61. doi:10.1016/j.ypmed.2015.12.018. PMC 4766366. PMID 26757401.
  - Thomas RE, Lorenzetti DL (May 2018). "Interventions to increase influenza vaccination rates of those 60 years and older in the community". The Cochrane Database of Systematic Reviews. 5 (5): CD005188. doi:10.1002/14651858.CD005188.pub4. PMC 6494593. PMID 29845606.
  - Chor JS, Ngai KL, Goggins WB, Wong MC, Wong SY, Lee N, et al. (August 2009). "Willingness of Hong Kong healthcare workers to accept pre-pandemic influenza vaccination at different WHO alert levels: two questionnaire surveys". BMJ. 339: b3391. doi:10.1136/bmj.b3391. PMC 2731837. PMID 19706937.
  - Nachbagauer R, Krammer F (April 2017). "Universal influenza virus vaccines and therapeutic antibodies". Clinical Microbiology and Infection. 23 (4): 222–228. doi:10.1016/j.cmi.2017.02.009. PMC 5389886. PMID 28216325.
  - Bernstein DI, Guptill J, Naficy A, Nachbagauer R, Berlanda-Scorza F, Feser J, et al. (January 2020). "Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial". The Lancet. Infectious Diseases. 20 (1): 80–91. doi:10.1016/S1473-3099(19)30393-7. PMC 6928577. PMID 31630990.
  - Sparrow E, Wood JG, Chadwick C, Newall AT, Torvaldsen S, Moen A, et al. (January 2021). "Global production capacity of seasonal and pandemic influenza vaccines in 2019". Vaccine. 39 (3): 512–520. doi:10.1016/j.vaccine.2020.12.018. PMC 7814984. PMID 33341308.
  - Jit M, Newall AT, Beutels P (April 2013). "Key issues for estimating the impact and cost-effectiveness of seasonal influenza vaccination strategies". Human Vaccines & Immunotherapeutics. 9 (4): 834–40. doi:10.4161/hv.23637. PMC 3903903. PMID 23357859.
  - Newall AT, Wood JG, Oudin N, MacIntyre CR (February 2010). "Cost-effectiveness of pharmaceutical-based pandemic influenza mitigation strategies". Emerging Infectious Diseases. 16 (2): 224–30. doi:10.3201/eid1602.090571. PMC 2957998. PMID 20113551.
  - Wagner M, Lampos V, Yom-Tov E, Pebody R, Cox IJ (December 2017). "Estimating the Population Impact of a New Pediatric Influenza Vaccination Program in England Using Social Media Content". Journal of Medical Internet Research. 19 (12): e416. doi:10.2196/jmir.8184. PMC 6257312. PMID 29269339.
  - Cho A, Wrammert J (April 2016). "Implications of broadly neutralizing antibodies in the development of a universal influenza vaccine". Current Opinion in Virology. 17: 110–115. doi:10.1016/j.coviro.2016.03.002. PMC 4940123. PMID 27031684.
  - Okuno Y, Isegawa Y, Sasao F, Ueda S (May 1993). "A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains". Journal of Virology. 67 (5): 2552–2558. doi:10.1128/JVI.67.5.2552-2558.1993. PMC 237575. PMID 7682624.
  - Deng L, Cho KJ, Fiers W, Saelens X (February 2015). "M2e-Based Universal Influenza A Vaccines". Vaccines. 3 (1): 105–36. doi:10.3390/vaccines3010105. PMC 4494237. PMID 26344949.
  - Toussi DN, Massari P (April 2014). "Immune Adjuvant Effect of Molecularly-defined Toll-Like Receptor Ligands". Vaccines. 2 (2): 323–53. doi:10.3390/vaccines2020323. PMC 4494261. PMID 26344622.
  nih.gov
  - "Priming with DNA vaccine makes avian flu vaccine work better (NIH News)". October 3, 2011. Archived from the original on September 27, 2012.
  niaid.nih.gov
  - "Influenza Genome Sequencing Project – Overview". National Institutes of Health – National Institute of Allergy and Infectious Diseases. Archived from the original on June 27, 2011. Retrieved May 27, 2013.

novartis.com

livestock.novartis.com

"Custom Vaccines: Swine". Archived from the original on April 30, 2009.

npr.org

Greenfieldboyce N (November 8, 2007). New and Old Ways to Make Flu Vaccines (Radio broadcast). NPR. Archived from the original on October 24, 2019. Retrieved October 23, 2019.

nsw.gov.au

health.nsw.gov.au

"Influenza fact sheet". Healthdirect, Department of Health, Government of Australia. April 1, 2019. Archived from the original on May 29, 2019. Retrieved May 29, 2019.

nytimes.com

McNeil Jr DG (October 1, 2018). "Over 80,000 Americans Died of Flu Last Winter, Highest Toll in Years". The New York Times. Archived from the original on October 1, 2018. Retrieved June 24, 2024.
Altman LK (February 28, 2008). "Panel Advises Flu Shots for Children Up to Age 18". The New York Times. Archived from the original on January 22, 2015.
McNeil Jr DG (May 2, 2006). "Turning to Chickens in Fight With Bird Flu". The New York Times. Archived from the original on November 14, 2012.

well.blogs.nytimes.com

Rabin RC (November 5, 2012). "Reassessing Flu Shots as the Season Draws Near". The New York Times. Archived from the original on November 10, 2016. Retrieved December 30, 2016. 'We have overpromoted and overhyped this vaccine,' said Michael T. Osterholm, director of the Center for Infectious Disease Research and Policy, as well as its Center of Excellence for Influenza Research and Surveillance. 'It does not protect as promoted. It's all a sales job: it's all public relations.'

oecd.org

data.oecd.org

"Health care use – Influenza vaccination rates – OECD Data". theOECD. Archived from the original on August 8, 2020. Retrieved April 24, 2020.

oup.com

academic.oup.com

Tenforde MW, Talbot HK, Trabue CH, Gaglani M, McNeal TS, Monto AS, et al. (December 30, 2020). "Influenza Vaccine Effectiveness Against Hospitalization in the United States, 2019–2020". The Journal of Infectious Diseases. 224 (5): 813–820. doi:10.1093/infdis/jiaa800. ISSN 0022-1899. PMC 8408767. PMID 33378531. Archived from the original on April 23, 2022. Retrieved April 23, 2022.

path.org

"Influenza Vaccine Strategies for Broad Global Access". Path. October 2007. Archived from the original on October 14, 2019. Retrieved September 16, 2009.

phac-aspc.gc.ca

National Advisory Committee on Immunization (NACI) (August 2012). "Statement on Seasonal Influenza Vaccine for 2012–2013" (PDF). Canada Communicable Disease Report. 38. Ottawa. Archived from the original (PDF) on January 17, 2013. Retrieved July 18, 2013.

prnewswire.com

"Novartis receives FDA approval for Flucelvax, the first cell-culture vaccine in US to help protect against seasonal influenza" (Press release). Novartis. November 20, 2012. Archived from the original on November 28, 2012.

psu.edu

citeseerx.ist.psu.edu

Osterholm MT (May 2005). "Preparing for the next pandemic". The New England Journal of Medicine. 352 (18): 1839–42. CiteSeerX 10.1.1.608.6200. doi:10.1056/NEJMp058068. PMID 15872196. S2CID 45893174.

publications.gc.ca

National Advisory Committee on Immunization (NACI) (July 2014). Literature review on quadrivalent influenza vaccines (PDF). Ottawa: Public Health Agency of Canada. ISBN 978-1-100-24682-6. Cat.: HP40-117/2014E-PDF Pub.: 140118. Archived (PDF) from the original on August 1, 2020. Retrieved January 11, 2020.
Literature review on influenza vaccination in healthy 5–18-year-olds (PDF) (Report). Ottawa: Public Health Agency of Canada. July 2014. ISBN 978-1-100-24681-9. Cat.: HP40-116/2014E-PDF Pub.: 140116. Archived (PDF) from the original on August 1, 2020. Retrieved January 12, 2020.
Literature review update on the efficacy and effectiveness of high-dose (Fluzone High-Dose) and MF59-adjuvanted (Fluad) trivalent inactivated influenza vaccines in adults 65 years of age and older (PDF) (Report). Ottawa: Public Health Agency of Canada. May 2018. HP40-210/2018E-PDF. Archived (PDF) from the original on July 21, 2020. Retrieved June 1, 2020.

reuters.com

Steenhuysen J (January 22, 2018). "U.S. CDC director urges flu vaccinations as pediatric deaths mount". Reuters. Archived from the original on May 6, 2021. Retrieved January 26, 2018.

sanofi.us

news.sanofi.us

"FDA approves Fluzone High-Dose Quadrivalent (Influenza Vaccine) for adults 65 years of age and older". Sanofi (Press release). November 4, 2019. Archived from the original on August 1, 2020. Retrieved February 5, 2020.

scidev.net

"Bird flu warning over partial protection of flocks". August 16, 2006. Archived from the original on September 26, 2007.

sciencebasedmedicine.org

"High Dose Flu Vaccine for the Elderly « Science-Based Medicine". Sciencebasedmedicine.org. October 19, 2010. Archived from the original on May 8, 2013. Retrieved October 17, 2013.

sciencedirect.com

Thompson MG, Pierse N, Huang QS, Prasad N, Duque J, Newbern EC, et al. (September 18, 2018). "Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012–2015". Vaccine. 36 (39): 5916–5925. doi:10.1016/j.vaccine.2018.07.028. ISSN 0264-410X. PMID 30077480. S2CID 51922011. Archived from the original on May 27, 2022. Retrieved April 23, 2022.
Ferdinands JM, Thompson MG, Blanton L, Spencer S, Grant L, Fry AM (June 23, 2021). "Does influenza vaccination attenuate the severity of breakthrough infections? A narrative review and recommendations for further research". Vaccine. 39 (28): 3678–3695. doi:10.1016/j.vaccine.2021.05.011. ISSN 0264-410X. PMID 34090700. S2CID 235361401. Archived from the original on April 23, 2022. Retrieved April 23, 2022.

semanticscholar.org

api.semanticscholar.org

Hampson AW (June 2008). "Vaccines for pandemic influenza. The history of our current vaccines, their limitations and the requirements to deal with a pandemic threat". Annals of the Academy of Medicine, Singapore. 37 (6): 510–17. doi:10.47102/annals-acadmedsg.V37N6p510. PMID 18618064. S2CID 17102174.
Osterholm MT (May 2005). "Preparing for the next pandemic". The New England Journal of Medicine. 352 (18): 1839–42. CiteSeerX 10.1.1.608.6200. doi:10.1056/NEJMp058068. PMID 15872196. S2CID 45893174.
Doshi P (September 20, 2018). "Pandemrix vaccine: why was the public not told of early warning signs?". BMJ. 362: k3948. doi:10.1136/bmj.k3948. ISSN 0959-8138. S2CID 52308748.
Doshi P (September 20, 2018). "Pandemrix vaccine: why was the public not told of early warning signs?". BMJ. 362: Infographic. doi:10.1136/bmj.k3948. S2CID 52308748.
Thompson MG, Pierse N, Huang QS, Prasad N, Duque J, Newbern EC, et al. (September 18, 2018). "Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012–2015". Vaccine. 36 (39): 5916–5925. doi:10.1016/j.vaccine.2018.07.028. ISSN 0264-410X. PMID 30077480. S2CID 51922011. Archived from the original on May 27, 2022. Retrieved April 23, 2022.
Ferdinands JM, Thompson MG, Blanton L, Spencer S, Grant L, Fry AM (June 23, 2021). "Does influenza vaccination attenuate the severity of breakthrough infections? A narrative review and recommendations for further research". Vaccine. 39 (28): 3678–3695. doi:10.1016/j.vaccine.2021.05.011. ISSN 0264-410X. PMID 34090700. S2CID 235361401. Archived from the original on April 23, 2022. Retrieved April 23, 2022.
Nichol KL, Nordin JD, Nelson DB, Mullooly JP, Hak E (October 2007). "Effectiveness of influenza vaccine in the community-dwelling elderly". The New England Journal of Medicine. 357 (14): 1373–81. doi:10.1056/NEJMoa070844. PMID 17914038. S2CID 14850833.
Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, et al. (January 2003). "Mortality associated with influenza and respiratory syncytial virus in the United States". JAMA. 289 (2): 179–86. doi:10.1001/jama.289.2.179. PMID 12517228. S2CID 5018362.
DiazGranados CA, Dunning AJ, Kimmel M, Kirby D, Treanor J, Collins A, et al. (August 2014). "Efficacy of high-dose versus standard-dose influenza vaccine in older adults". The New England Journal of Medicine. 371 (7): 635–45. doi:10.1056/NEJMoa1315727. PMID 25119609. S2CID 205096393.
Haber P, Sejvar J, Mikaeloff Y, DeStefano F (2009). "Vaccines and Guillain-Barré syndrome". Drug Safety. 32 (4): 309–23. doi:10.2165/00002018-200932040-00005. PMID 19388722. S2CID 33670594.
"Reorganized text". JAMA Otolaryngology–Head & Neck Surgery. 141 (5): 428. May 2015. doi:10.1001/jamaoto.2015.0540. PMID 25996397. S2CID 26612829.
Greenhawt M (December 2015). "Live attenuated influenza vaccine for children with egg allergy". BMJ. 351: h6656. doi:10.1136/bmj.h6656. PMID 26657778. S2CID 37037904.
Yong E (2013). "Narcolepsy confirmed as autoimmune disease". Nature. doi:10.1038/nature.2013.14413. S2CID 74850662.
Offit PA (September 2007). "Thimerosal and vaccines – a cautionary tale". The New England Journal of Medicine. 357 (13): 1278–79. doi:10.1056/NEJMp078187. PMID 17898096. S2CID 36318722.
Lee JK, Lam GK, Shin T, Kim J, Krishnan A, Greenberg DP, et al. (May 2018). "Efficacy and effectiveness of high-dose versus standard-dose influenza vaccination for older adults: a systematic review and meta-analysis". Expert Rev Vaccines. 17 (5): 435–443. doi:10.1080/14760584.2018.1471989. PMID 29715054. S2CID 21688517.
Bull AL, Bennett N, Pitcher HC, Russo PL, Richards MJ (February 2007). "Influenza vaccine coverage among health care workers in Victorian public hospitals". The Medical Journal of Australia. 186 (4): 185–86. doi:10.5694/j.1326-5377.2007.tb00858.x. PMID 17309419. S2CID 25091208.
Abbasi J (November 2019). "The Search for a Universal Flu Vaccine Heats Up". JAMA. 322 (20): 1942–1944. doi:10.1001/jama.2019.16816. PMID 31693060. S2CID 207903441.
Postma MJ, Baltussen RP, Palache AM, Wilschut JC (April 2006). "Further evidence for favorable cost-effectiveness of elderly influenza vaccination". Expert Review of Pharmacoeconomics & Outcomes Research. 6 (2): 215–27. doi:10.1586/14737167.6.2.215. PMID 20528557. S2CID 12765724.
Newall AT, Kelly H, Harsley S, Scuffham PA (2009). "Cost effectiveness of influenza vaccination in older adults: a critical review of economic evaluations for the 50- to 64-year age group". PharmacoEconomics. 27 (6): 439–50. doi:10.2165/00019053-200927060-00001. PMID 19640008. S2CID 20855671.
Newall AT, Viboud C, Wood JG (June 2010). "Influenza-attributable mortality in Australians aged more than 50 years: a comparison of different modelling approaches". Epidemiology and Infection. 138 (6): 836–42. doi:10.1017/S095026880999118X. PMID 19941685. S2CID 29939376.
Newall AT, Dehollain JP, Creighton P, Beutels P, Wood JG (August 2013). "Understanding the cost-effectiveness of influenza vaccination in children: methodological choices and seasonal variability". PharmacoEconomics. 31 (8): 693–702. doi:10.1007/s40273-013-0060-7. PMID 23645539. S2CID 8616720.
Newall AT, Scuffham PA (December 2011). "Uncertainty and variability in influenza cost-effectiveness models". Australian and New Zealand Journal of Public Health. 35 (6): 576, author reply 576–77. doi:10.1111/j.1753-6405.2011.00788.x. PMID 22151168. S2CID 22402257.
Gatwood J, Meltzer MI, Messonnier M, Ortega-Sanchez IR, Balkrishnan R, Prosser LA (January 2012). "Seasonal influenza vaccination of healthy working-age adults: a review of economic evaluations". Drugs. 72 (1): 35–48. doi:10.2165/11597310-000000000-00000. PMID 22191794. S2CID 46305863.
Newall AT, Jit M, Beutels P (August 2012). "Economic evaluations of childhood influenza vaccination: a critical review". PharmacoEconomics. 30 (8): 647–60. doi:10.2165/11599130-000000000-00000. PMID 22788257. S2CID 38289883.
Lampos V, Yom-Tov E, Pebody R, Cox IJ (2015). "Assessing the impact of a health intervention via user-generated Internet content" (PDF). Data Mining and Knowledge Discovery. 29 (5): 1434–57. doi:10.1007/s10618-015-0427-9. S2CID 215415165. Archived from the original on August 28, 2021. Retrieved August 15, 2022.
Liebowitz D, Gottlieb K, Kolhatkar NS, Garg SJ, Asher JM, Nazareno J, et al. (April 2020). "Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study". The Lancet. Infectious Diseases. 20 (4). Elsevier: 435–444. doi:10.1016/S1473-3099(19)30584-5. PMID 31978354. S2CID 210892802.
Callaway E (May 16, 2022). "Flu vaccine could cut COVID risk". Nature. 605 (7911): 602. Bibcode:2022Natur.605..602C. doi:10.1038/d41586-022-01315-9. PMID 35581411. S2CID 248859545.
Yen HL, Peiris JS (May 2012). "Virology: bird flu in mammals". Nature. 486 (7403): 332–33. Bibcode:2012Natur.486..332Y. doi:10.1038/nature11192. PMID 22722190. S2CID 205229301.

seqirus.com

"Seqirus receives FDA approval for Flucelvax Quadrivalent (Influenza Vaccine) for people four years of age and older" (Press release). Seqirus. May 23, 2016. Archived from the original on January 16, 2017. Retrieved January 15, 2017.

seqirus.us

"Seqirus Receives FDA Approval for Fluad Quadrivalent for Adults 65 Years and Older". Seqirus (Press release). February 24, 2020. Archived from the original on August 26, 2020. Retrieved August 25, 2020.
"Seqirus Begins Shipping 2020/21 Influenza Vaccines to U.S. Market". Seqirus (Press release). July 30, 2020. Archived from the original on August 26, 2020. Retrieved August 25, 2020.

tga.gov.au

"AusPAR: Influenza Haemagglutinin Recombinant". Therapeutic Goods Administration (TGA). August 23, 2021. Archived from the original on September 11, 2021. Retrieved September 10, 2021.
"AusPAR: Inactivated quadrivalent influenza vaccine (split virion) influenza virus haemagglutinin". Therapeutic Goods Administration (TGA). December 2, 2020. Archived from the original on September 11, 2021. Retrieved September 10, 2021.
"Updates to the Prescribing Medicines in Pregnancy database". Therapeutic Goods Administration (TGA). December 21, 2022. Archived from the original on April 3, 2022. Retrieved January 2, 2023.
"Prescription medicines: registration of new chemical entities in Australia, 2017". Therapeutic Goods Administration (TGA). June 21, 2022. Archived from the original on April 10, 2023. Retrieved April 9, 2023.
"Prescription medicines: registration of new chemical entities in Australia, 2016". Therapeutic Goods Administration (TGA). June 21, 2022. Archived from the original on April 10, 2023. Retrieved April 10, 2023.
https://www.tga.gov.au/resources/auspar/auspar-flucelvax-quad-0
"Fluad Quad Australian prescription medicine decision summary". Therapeutic Goods Administration (TGA). December 13, 2019. Archived from the original on March 8, 2020. Retrieved August 24, 2020.

theatlantic.com

Brownlee S (November 1, 2009). "Does the Vaccine Matter?". The Atlantic. Archived from the original on December 9, 2014. Retrieved December 8, 2014.

uaeequafed.ae

"UAE Equestrian & Racing Federation". March 22, 2005. Archived from the original on March 22, 2005.

ucl.ac.uk

discovery.ucl.ac.uk

Lampos V, Yom-Tov E, Pebody R, Cox IJ (2015). "Assessing the impact of a health intervention via user-generated Internet content" (PDF). Data Mining and Knowledge Discovery. 29 (5): 1434–57. doi:10.1007/s10618-015-0427-9. S2CID 215415165. Archived from the original on August 28, 2021. Retrieved August 15, 2022.

umn.edu

cidrap.umn.edu

Schnirring L (September 29, 2023). "WHO advisers recommend switch back to trivalent flu vaccines". CIDRAP. Archived from the original on December 18, 2023. Retrieved October 26, 2023.
Schnirring L (August 18, 2011). "CDC updates flu vaccination recommendations". Center for Infectious Disease Research and Policy (CIDRAP). Archived from the original on October 25, 2019. Retrieved October 24, 2019.
Roos R (October 14, 2019). "FDA approves first flu vaccine grown in insect cells". Center for Infectious Disease Research and Policy (CIDRAP). Archived from the original on October 14, 2019. Retrieved October 14, 2019.

usnews.com

health.usnews.com

Reinberg S (February 2, 2011). "Last Year's H1N1 Flu Vaccine Was Safe, Study Finds". U.S. News & World Report. Archived from the original on April 25, 2013.

virology.ws

Racaniello V (December 2009). "Influenza virus growth in eggs". Virology Blog. Archived from the original on December 25, 2014.

web.archive.org

"AusPAR: Influenza Haemagglutinin Recombinant". Therapeutic Goods Administration (TGA). August 23, 2021. Archived from the original on September 11, 2021. Retrieved September 10, 2021.
"AusPAR: Inactivated quadrivalent influenza vaccine (split virion) influenza virus haemagglutinin". Therapeutic Goods Administration (TGA). December 2, 2020. Archived from the original on September 11, 2021. Retrieved September 10, 2021.
"Updates to the Prescribing Medicines in Pregnancy database". Therapeutic Goods Administration (TGA). December 21, 2022. Archived from the original on April 3, 2022. Retrieved January 2, 2023.
"Prescription medicines: registration of new chemical entities in Australia, 2017". Therapeutic Goods Administration (TGA). June 21, 2022. Archived from the original on April 10, 2023. Retrieved April 9, 2023.
"Prescription medicines: registration of new chemical entities in Australia, 2016". Therapeutic Goods Administration (TGA). June 21, 2022. Archived from the original on April 10, 2023. Retrieved April 10, 2023.
"Summary Basis of Decision (SBD) for Supemtek". Health Canada. October 23, 2014. Archived from the original on May 30, 2022. Retrieved May 29, 2022.
"Regulatory Decision Summary - Flucelvax Quad". Health Canada. October 23, 2014. Archived from the original on June 7, 2022. Retrieved June 7, 2022.
"Regulatory Decision Summary - Flucelvax Quad". Health Canada. October 23, 2014. Archived from the original on June 7, 2022. Retrieved June 7, 2022.
"Regulatory Decision Summary - Influvac Tetra". Health Canada. October 23, 2014. Archived from the original on June 7, 2022. Retrieved June 7, 2022.
Compans RW (2009). Vaccines for pandemic influenza. Dordrecht: Springer. p. 49. ISBN 978-3-540-92165-3. Archived from the original on August 3, 2020. Retrieved September 9, 2017.
Vaccine Analysis: Strategies, Principles, and Control. Springer. 2014. p. 61. ISBN 978-3-662-45024-6. Archived from the original on August 3, 2020. Retrieved September 9, 2017.
"Who Should and Who Should NOT get a Flu Vaccine". U.S. Centers for Disease Control and Prevention (CDC). October 11, 2019. Archived from the original on December 2, 2019. Retrieved December 2, 2019. This article incorporates text from this source, which is in the public domain.
Grohskopf LA, Alyanak E, Ferdinands JM, Broder KR, Blanton LH, Talbot HK, et al. (August 2021). "Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season" (PDF). MMWR Recomm Rep. 70 (5): 1–28. doi:10.15585/mmwr.rr7005a1. PMC 8407757. PMID 34448800. Archived (PDF) from the original on August 27, 2021. Retrieved August 29, 2021. This article incorporates text from this source, which is in the public domain.
"Implementation of the Council Recommendation on seasonal influenza vaccination (2009/1019/EU)" (PDF). European Centre for Disease Prevention and Control. January 2014. Archived (PDF) from the original on April 10, 2020. Retrieved April 10, 2020.
- Lay summary in: "Implementation of the Council Recommendation on seasonal influenza vaccination". European Centre for Disease Prevention and Control. January 9, 2014.
- "Flu Vaccine and People with Egg Allergies". U.S. Centers for Disease Control and Prevention (CDC). November 25, 2019. Archived from the original on December 2, 2019. Retrieved December 2, 2019. This article incorporates text from this source, which is in the public domain.
- "Intradermal Influenza (Flu) Vaccination". U.S. Centers for Disease Control and Prevention (CDC). October 31, 2018. Archived from the original on October 14, 2019. Retrieved October 14, 2019. This article incorporates text from this source, which is in the public domain.
- "Influenza vaccines – United States, 2019–20 influenza season". U.S. Centers for Disease Control and Prevention (CDC). August 22, 2019. Archived from the original on October 14, 2019. Retrieved October 14, 2019. This article incorporates text from this source, which is in the public domain.
- "Influenza Virus Vaccine Inactivated". The American Society of Health-System Pharmacists. November 19, 2018. Archived from the original on October 14, 2019. Retrieved October 13, 2019.
- "FDA approves first seasonal influenza vaccine manufactured using cell culture technology" (Press release). U.S. Food and Drug Administration (FDA). Archived from the original on January 2, 2013. This article incorporates text from this source, which is in the public domain.
- "Cell-Based Flu Vaccines". U.S. Centers for Disease Control and Prevention (CDC). October 11, 2019. Archived from the original on December 2, 2019. Retrieved December 2, 2019. This article incorporates text from this source, which is in the public domain.
- "FDA approves new seasonal influenza vaccine made using novel technology" (Press release). U.S. Food and Drug Administration (FDA). January 16, 2013. Archived from the original on May 18, 2013. This article incorporates text from this source, which is in the public domain.
- "Swine Flu Epidemics". October 9, 1999. Archived from the original on October 9, 1999.
- "First Quadrivalent Vaccine Against Seasonal Flu Wins FDA Approval". March 2, 2012. Archived from the original on March 4, 2012.
- "FDA approves first quadrivalent vaccine to prevent seasonal influenza" (Press release). U.S. Food and Drug Administration (FDA). Archived from the original on December 21, 2012. This article incorporates text from this source, which is in the public domain.
- "December 14, 2012 Approval Letter – Fluarix Quadrivalent". U.S. Food and Drug Administration (FDA). Archived from the original on January 2, 2013. This article incorporates text from this source, which is in the public domain.
- National Advisory Committee on Immunization (NACI) (July 2014). Literature review on quadrivalent influenza vaccines (PDF). Ottawa: Public Health Agency of Canada. ISBN 978-1-100-24682-6. Cat.: HP40-117/2014E-PDF Pub.: 140118. Archived (PDF) from the original on August 1, 2020. Retrieved January 11, 2020.
- "What You Should Know for the 2018-2019 Influenza Season". Centers for Disease Control and Prevention (CDC). January 10, 2019. Archived from the original on August 6, 2020. Retrieved February 5, 2020. This article incorporates text from this source, which is in the public domain.
- "Frequently Asked Influenza (Flu) Questions: 2019–2020 Season". U.S. Centers for Disease Control and Prevention (CDC). November 5, 2019. Archived from the original on December 1, 2019. Retrieved November 30, 2019. This article incorporates text from this source, which is in the public domain.
- "Fluzone High-Dose Quadrivalent". U.S. Food and Drug Administration (FDA). November 4, 2019. STN: BL 103914. Archived from the original on January 12, 2020. Retrieved February 5, 2020. This article incorporates text from this source, which is in the public domain.
- "FDA approves Fluzone High-Dose Quadrivalent (Influenza Vaccine) for adults 65 years of age and older". Sanofi (Press release). November 4, 2019. Archived from the original on August 1, 2020. Retrieved February 5, 2020.
- "Fluad Quadrivalent". U.S. Food and Drug Administration (FDA). July 2, 2020. STN: 125510. Archived from the original on August 11, 2020. Retrieved August 25, 2020. This article incorporates text from this source, which is in the public domain.
- "Seqirus Receives FDA Approval for Fluad Quadrivalent for Adults 65 Years and Older". Seqirus (Press release). February 24, 2020. Archived from the original on August 26, 2020. Retrieved August 25, 2020.
- "Seqirus Begins Shipping 2020/21 Influenza Vaccines to U.S. Market". Seqirus (Press release). July 30, 2020. Archived from the original on August 26, 2020. Retrieved August 25, 2020.
- World Health Organization (September 29, 2023). "Questions and Answers: Recommended composition of influenza virus vaccines for use in the southern hemisphere 2024 influenza season and development of candidate vaccine viruses for pandemic preparedness" (PDF). Archived (PDF) from the original on October 10, 2023. Retrieved October 26, 2023.
- Schnirring L (September 29, 2023). "WHO advisers recommend switch back to trivalent flu vaccines". CIDRAP. Archived from the original on December 18, 2023. Retrieved October 26, 2023.
- "Use of Trivalent Influenza Vaccines for the 2024-2025 U.S. flu season". U.S. Food and Drug Administration (FDA). March 5, 2024. Archived from the original on March 7, 2024. Retrieved March 7, 2024. This article incorporates text from this source, which is in the public domain.
- "Key Facts About Seasonal Flu Vaccine". U.S. Centers for Disease Control and Prevention (CDC). December 2, 2019. Archived from the original on December 2, 2019. Retrieved December 2, 2019. This article incorporates text from this source, which is in the public domain.
- "Flu vaccine". UK National Health Service. May 13, 2022. Archived from the original on October 26, 2021. Retrieved August 13, 2022.
- "Past Seasons Vaccine Effectiveness Estimates". U.S. Centers for Disease Control and Prevention (CDC). January 29, 2020. Archived from the original on February 12, 2020. Retrieved March 4, 2019. This article incorporates text from this source, which is in the public domain.
- Centers for Disease Control Prevention (CDC) (August 13, 2004). "Assessment of the effectiveness of the 2003-04 influenza vaccine among children and adults--Colorado, 2003". MMWR. Morbidity and Mortality Weekly Report. 53 (31). Centers for Disease Control and Prevention: 707–710. ISSN 1545-861X. PMID 15306754. Archived from the original on April 27, 2022. Retrieved April 27, 2022. At table.
- Centers for Disease Control Prevention (CDC) (January 16, 2004). "Preliminary assessment of the effectiveness of the 2003-04 inactivated influenza vaccine--Colorado, December 2003". MMWR. Morbidity and Mortality Weekly Report. 53 (1). Centers for Disease Control and Prevention: 8–11. ISSN 1545-861X. PMID 14724559. Archived from the original on May 29, 2022. Retrieved April 25, 2022.
- "Past Weekly Surveillance Reports". Centers for Disease Control and Prevention. April 29, 2022. Archived from the original on April 22, 2022. Retrieved April 25, 2022.
- Chung JR (March 11, 2022). "Interim Estimates of 2021–22 Seasonal Influenza Vaccine Effectiveness — United States, February 2022". MMWR. Morbidity and Mortality Weekly Report. 71 (10): 365–370. doi:10.15585/mmwr.mm7110a1. ISSN 0149-2195. PMC 8911998. PMID 35271561. Archived from the original on May 16, 2022. Retrieved May 25, 2022.
- Eamon N. Dreisbach (June 3, 2021). "CDC unable to estimate flu vaccine effectiveness after historically mild season". Healio. Archived from the original on October 8, 2021. Retrieved April 18, 2022.
- "2007–2008 Influenza (Flu) Season". U.S. Centers for Disease Control and Prevention (CDC). June 26, 2008. Archived from the original on March 6, 2008. This article incorporates text from this source, which is in the public domain.
- Thompson MG, Pierse N, Huang QS, Prasad N, Duque J, Newbern EC, et al. (September 18, 2018). "Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012–2015". Vaccine. 36 (39): 5916–5925. doi:10.1016/j.vaccine.2018.07.028. ISSN 0264-410X. PMID 30077480. S2CID 51922011. Archived from the original on May 27, 2022. Retrieved April 23, 2022.
- Tenforde MW, Talbot HK, Trabue CH, Gaglani M, McNeal TS, Monto AS, et al. (December 30, 2020). "Influenza Vaccine Effectiveness Against Hospitalization in the United States, 2019–2020". The Journal of Infectious Diseases. 224 (5): 813–820. doi:10.1093/infdis/jiaa800. ISSN 0022-1899. PMC 8408767. PMID 33378531. Archived from the original on April 23, 2022. Retrieved April 23, 2022.
- Ferdinands JM, Thompson MG, Blanton L, Spencer S, Grant L, Fry AM (June 23, 2021). "Does influenza vaccination attenuate the severity of breakthrough infections? A narrative review and recommendations for further research". Vaccine. 39 (28): 3678–3695. doi:10.1016/j.vaccine.2021.05.011. ISSN 0264-410X. PMID 34090700. S2CID 235361401. Archived from the original on April 23, 2022. Retrieved April 23, 2022.
- "Vaccine Effectiveness: How Well Do the Flu Vaccines Work?". U.S. Centers for Disease Control and Prevention (CDC). October 12, 2018. Archived from the original on October 25, 2019. Retrieved October 24, 2019. This article incorporates text from this source, which is in the public domain.
- Gemmill I, Young K (June 7, 2018). "Summary of the NACI literature review on the comparative effectiveness of subunit and split virus inactivated influenza vaccines in older adults". Canada Communicable Disease Report. 44 (6): 129–133. doi:10.14745/ccdr.v44i06a02. ISSN 1481-8531. PMC 6449119. PMID 31015805. Archived from the original on May 17, 2020. Retrieved June 2, 2020.
- "Flu & People 65 Years and Older". Centers for Disease Control and Prevention. August 26, 2021. Archived from the original on April 22, 2022. Retrieved April 21, 2022.
- "Influenza Historic Timeline | Pandemic Influenza (Flu) | CDC". March 11, 2020. Archived from the original on January 30, 2022. Retrieved January 27, 2022.
- "Influenza (Seasonal)". World Health Organization (WHO). November 6, 2018. Archived from the original on October 25, 2019. Retrieved October 24, 2019.
- "Study of Flu-Related Deaths in Children Shows Healthy Children at Risk". U.S. Centers for Disease Control and Prevention (CDC). February 12, 2018. Archived from the original on December 2, 2019. Retrieved December 2, 2019. This article incorporates text from this source, which is in the public domain.
- Steenhuysen J (January 22, 2018). "U.S. CDC director urges flu vaccinations as pediatric deaths mount". Reuters. Archived from the original on May 6, 2021. Retrieved January 26, 2018.
- "Fluzone High-Dose Quadrivalent". U.S. Food and Drug Administration (FDA). November 14, 2019. Archived from the original on December 1, 2019. Retrieved November 30, 2019. This article incorporates text from this source, which is in the public domain.
- "Afluria Quadrivalent". U.S. Food and Drug Administration (FDA). November 8, 2019. Archived from the original on December 1, 2019. Retrieved November 30, 2019. This article incorporates text from this source, which is in the public domain.
- National Advisory Committee on Immunization (NACI) (November 2018). "Supplemental Statement – Afluria Tetra – An Advisory Committee Statement (ACS)". Public Health Agency of Canada. Ottawa. Cat.: HP37-25E-PDF Pub.: 180566. Archived from the original on January 12, 2020. Retrieved January 11, 2020.
- Literature review on influenza vaccination in healthy 5–18-year-olds (PDF) (Report). Ottawa: Public Health Agency of Canada. July 2014. ISBN 978-1-100-24681-9. Cat.: HP40-116/2014E-PDF Pub.: 140116. Archived (PDF) from the original on August 1, 2020. Retrieved January 12, 2020.
- Literature Review on Pediatric Fluad Influenza Vaccine Use in Children 6–72 Months of Age (PDF) (Report). Ottawa: Public Health Agency of Canada. 2015. Archived (PDF) from the original on May 17, 2020. Retrieved January 11, 2020.
- "High Dose Flu Vaccine for the Elderly « Science-Based Medicine". Sciencebasedmedicine.org. October 19, 2010. Archived from the original on May 8, 2013. Retrieved October 17, 2013.
- "Fluzone High-Dose Seasonal Influenza Vaccine". U.S. Centers for Disease Control and Prevention (CDC). September 6, 2019. Archived from the original on December 2, 2019. Retrieved December 2, 2019.
- Wells C, Grobelna A (January 8, 2019). "High Dose Influenza Vaccine for Adults: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines" (PDF). Rapid Response Report. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). ISSN 1922-8147. PMID 31141324. Archived (PDF) from the original on August 1, 2020. Retrieved August 15, 2022.
- "FDA approves first seasonal influenza vaccine containing an adjuvant" (Press release). U.S. Food and Drug Administration (FDA). November 24, 2015. Archived from the original on July 22, 2017. Retrieved August 20, 2017. This article incorporates text from this source, which is in the public domain.
- "Flu Vaccine With Adjuvant". U.S. Centers for Disease Control and Prevention (CDC). September 4, 2019. Archived from the original on December 2, 2019. Retrieved December 2, 2019. This article incorporates text from this source, which is in the public domain.
- "Fluad". U.S. Food and Drug Administration (FDA). November 8, 2019. STN 125510. Archived from the original on December 2, 2019. Retrieved December 2, 2019. This article incorporates text from this source, which is in the public domain.
- "Fluad Quad Australian prescription medicine decision summary". Therapeutic Goods Administration (TGA). December 13, 2019. Archived from the original on March 8, 2020. Retrieved August 24, 2020.
- "Fluad Tetra EPAR". European Medicines Agency (EMA). March 24, 2020. Archived from the original on August 1, 2020. Retrieved May 29, 2020.
- "Fluad Tetra Product information". Union Register of medicinal products. Archived from the original on March 5, 2023. Retrieved March 3, 2023.
- "Flu shot". CDC. 2020. Archived from the original on December 2, 2019. Retrieved September 24, 2020.
- "Misconceptions about flu vaccines". CDC. 2020. Archived from the original on August 10, 2020. Retrieved September 24, 2020.
- McNeil Jr DG (October 1, 2018). "Over 80,000 Americans Died of Flu Last Winter, Highest Toll in Years". The New York Times. Archived from the original on October 1, 2018. Retrieved June 24, 2024.
- "5 myths about the flu vaccine". World Health Organization. Archived from the original on February 14, 2024. Retrieved June 24, 2024.
- Vellozzi C, Burwen DR, Dobardzic A, Ball R, Walton K, Haber P (March 2009). "Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring". Vaccine. 27 (15): 2114–20. doi:10.1016/j.vaccine.2009.01.125. PMID 19356614. Archived from the original on August 1, 2020. Retrieved May 21, 2020.
- Reinberg S (February 2, 2011). "Last Year's H1N1 Flu Vaccine Was Safe, Study Finds". U.S. News & World Report. Archived from the original on April 25, 2013.
- Roberts L (March 27, 2021). "Australia's first cell-based influenza vaccines to roll out this flu season". ABC News. Archived from the original on April 27, 2021. Retrieved April 28, 2021.
- National Advisory Committee on Immunization (NACI) (August 2012). "Statement on Seasonal Influenza Vaccine for 2012–2013" (PDF). Canada Communicable Disease Report. 38. Ottawa. Archived from the original (PDF) on January 17, 2013. Retrieved July 18, 2013.
- "Novartis receives FDA approval for Flucelvax, the first cell-culture vaccine in US to help protect against seasonal influenza" (Press release). Novartis. November 20, 2012. Archived from the original on November 28, 2012.
- "Supemtek EPAR". European Medicines Agency (EMA). September 15, 2020. Archived from the original on January 10, 2021. Retrieved November 27, 2020.
- Technical Report: Narcolepsy in association with pandemic influenza vaccination (PDF). Stockholm, Sweden: European Centre for Disease Prevention and Control (ECDC). 2012. ISBN 978-92-9193-388-4. Archived from the original (PDF) on December 31, 2013. Retrieved December 30, 2013.
- "Thimerosal in Flu Vaccine". U.S. Centers for Disease Control and Prevention. October 16, 2015. Archived from the original on December 2, 2019. Retrieved December 2, 2019. This article incorporates text from this source, which is in the public domain.
- "Thimerosal in Vaccines Thimerosal – Concerns – Vaccine Safety". U.S. Centers for Disease Control and Prevention. October 27, 2015. Archived from the original on November 2, 2019. Retrieved December 2, 2019. This article incorporates text from this source, which is in the public domain.
- Global Advisory Committee on Vaccine Safety (July 14, 2006). "Thiomersal and vaccines". World Health Organization (WHO). Archived from the original on November 6, 2009. Retrieved November 20, 2007.
- Product Monograph: Flumist (PDF), Astrazeneca Canada Inc., June 20, 2014, archived (PDF) from the original on September 30, 2020, retrieved September 5, 2020
- "Seasonal Flu Shot". U.S. Centers for Disease Control and Prevention (CDC). December 9, 2019. Archived from the original on December 2, 2019. Retrieved January 12, 2020. This article incorporates text from this source, which is in the public domain.
- "Vaccine use". World Health Organization (WHO). Archived from the original on December 15, 2012. Retrieved January 15, 2017.
- "Influenza (Seasonal) Fact sheet". World Health Organization (WHO). November 2016. Archived from the original on November 30, 2014. Retrieved January 15, 2017.
- "Influenza (Seasonal)". WHO. November 6, 2018. Archived from the original on October 14, 2019. Retrieved October 14, 2019.
- "Methods for assessing influenza vaccination coverage in target groups (2016)". WHO/Europe. March 19, 2018. Archived from the original on October 14, 2019. Retrieved October 14, 2019.
- "Recommendations on influenza vaccination during the 2019–2020 winter season". WHO/Europe. September 24, 2019. Archived from the original on October 14, 2019. Retrieved October 14, 2019.
- Canadian Immunization Guide Chapter on Influenza and Statement on Seasonal Influenza Vaccine for 2019–2020 (PDF) (Report). Public Health Agency of Canada. May 2019. Cat.: HP37-25E-PDF; Pub.: 180883. Archived (PDF) from the original on July 16, 2020. Retrieved June 2, 2020.
- "Risk groups for severe influenza". European Centre for Disease Prevention and Control (ECDC). October 20, 2017. Archived from the original on October 22, 2019. Retrieved October 22, 2019.
- "ECDC Reviews – New WHO recommendations on seasonal influenza ..." European Centre for Disease Prevention and Control (ECDC). Archived from the original on May 10, 2017. Retrieved December 25, 2016.
- "ECDC Guidance: Priority risk groups for influenza vaccination" (PDF). European Centre for Disease Prevention and Control (ECDC). pp. 7–8. Archived from the original (PDF) on December 25, 2016. Retrieved December 25, 2016.
- "Children & Influenza (Flu)". U.S. Centers for Disease Control and Prevention (CDC). October 23, 2019. Archived from the original on November 11, 2019. This article incorporates text from this source, which is in the public domain.
- Rahman K (October 21, 2021). "Full List of Vaccines Mandated by the U.S. Military". Newsweek. Archived from the original on December 19, 2023.
- "Live Attenuated Influenza Vaccine [LAIV] (The Nasal Spray Flu Vaccine)". U.S. Centers for Disease Control and Prevention (CDC). September 16, 2019. Archived from the original on October 14, 2019. Retrieved October 14, 2019. This article incorporates text from this source, which is in the public domain.
- "Influenza Vaccination: A Summary for Clinicians – Health Professionals – Seasonal Influenza (Flu)". U.S. Centers for Disease Control and Prevention (CDC). September 6, 2018. Archived from the original on February 24, 2008. This article incorporates text from this source, which is in the public domain.
- Literature review update on the efficacy and effectiveness of high-dose (Fluzone High-Dose) and MF59-adjuvanted (Fluad) trivalent inactivated influenza vaccines in adults 65 years of age and older (PDF) (Report). Ottawa: Public Health Agency of Canada. May 2018. HP40-210/2018E-PDF. Archived (PDF) from the original on July 21, 2020. Retrieved June 1, 2020.
- Tanner L (January 13, 2013). "Hospitals crack down on workers who refuse flu shots". NBC News. Archived from the original on December 3, 2013. Retrieved July 24, 2014.
- Centers for Disease Control Prevention (CDC) (December 2010). "Seasonal influenza and 2009 H1N1 influenza vaccination coverage among pregnant women – 10 states, 2009–10 influenza season" (PDF). Morbidity and Mortality Weekly Report (MMWR). 59 (47): 1541–45. PMID 21124293. Archived (PDF) from the original on June 25, 2017. This article incorporates text from this source, which is in the public domain.
- Altman LK (February 28, 2008). "Panel Advises Flu Shots for Children Up to Age 18". The New York Times. Archived from the original on January 22, 2015.
- "ACIP votes down use of LAIV for 2016–2017 flu season" (Press release). U.S. Centers for Disease Control and Prevention (CDC). June 22, 2016. Archived from the original on November 25, 2016. Retrieved November 26, 2016. This article incorporates text from this source, which is in the public domain.
- "Immunization Schedules". U.S. Centers for Disease Control and Prevention (CDC). Archived from the original on November 5, 2014. Retrieved November 4, 2014. This article incorporates text from this source, which is in the public domain.
- "Flu vaccine FAQs". Healthdirect, Department of Health, Government of Australia. April 1, 2019. Archived from the original on May 29, 2019. Retrieved May 29, 2019.
- "Influenza fact sheet". Healthdirect, Department of Health, Government of Australia. April 1, 2019. Archived from the original on May 29, 2019. Retrieved May 29, 2019.
- "Health care use – Influenza vaccination rates – OECD Data". theOECD. Archived from the original on August 8, 2020. Retrieved April 24, 2020.
- Centers for Disease Control Prevention (CDC) (October 2009). "Update on influenza A (H1N1) 2009 monovalent vaccines" (PDF). Morbidity and Mortality Weekly Report (MMWR). 58 (39): 1100–01. PMID 19816398. Archived (PDF) from the original on June 29, 2011. This article incorporates text from this source, which is in the public domain.
- Schnirring L (August 18, 2011). "CDC updates flu vaccination recommendations". Center for Infectious Disease Research and Policy (CIDRAP). Archived from the original on October 25, 2019. Retrieved October 24, 2019.
- Centers for Disease Control Prevention (CDC) (August 2011). "Influenza vaccination coverage among health-care personnel – United States, 2010–11 influenza season" (PDF). Morbidity and Mortality Weekly Report (MMWR). 60 (32): 1073–77. PMID 21849963. Archived (PDF) from the original on May 25, 2017. This article incorporates text from this source, which is in the public domain.
- Centers for Disease Control Prevention (CDC) (September 2012). "Influenza vaccination coverage among health-care personnel: 2011–12 influenza season, United States" (PDF). Morbidity and Mortality Weekly Report (MMWR). 61: 753–57. PMID 23013720. Archived (PDF) from the original on June 24, 2017. This article incorporates text from this source, which is in the public domain.
- Greenfieldboyce N (November 8, 2007). New and Old Ways to Make Flu Vaccines (Radio broadcast). NPR. Archived from the original on October 24, 2019. Retrieved October 23, 2019.
- Balfour H (June 2, 2021). "First-in-human universal flu vaccine trial begins". European Pharmaceutical Review. Archived from the original on March 29, 2022. Retrieved February 6, 2022. The Phase I trial (NCT04896086) will assess the safety and immunogenicity of the experimental vaccine, FluMos-v1
- "Influenza Vaccine Strategies for Broad Global Access". Path. October 2007. Archived from the original on October 14, 2019. Retrieved September 16, 2009.
- "how it's made" (PDF). Archived from the original (PDF) on July 5, 2010.
- "Influenza vaccine viruses and reagents". World Health Organization (WHO). Archived from the original on May 27, 2013.
- "Recommendations for the production and control of influenza vaccine (inactivated)" (PDF). World Health Organization (WHO). Archived (PDF) from the original on October 28, 2013. Retrieved May 27, 2013.
- Racaniello V (December 2009). "Influenza virus growth in eggs". Virology Blog. Archived from the original on December 25, 2014.
- Izzat F (April 2012). "Viral Cultivation in Chicken Embryo". Youtube. Archived from the original on May 26, 2015.
- "How Influenza (Flu) Vaccines Are Made". U.S. Centers for Disease Control and Prevention (CDC). November 26, 2019. Archived from the original on December 2, 2019. Retrieved December 2, 2019. This article incorporates text from this source, which is in the public domain.
- Seemann G, Kock M (2008). "Fertile eggs – a valuable product for vaccine production". Lohmann Breeders. Archived from the original on November 23, 2023. Retrieved October 19, 2023.
- "Priming with DNA vaccine makes avian flu vaccine work better (NIH News)". October 3, 2011. Archived from the original on September 27, 2012.
- Center for Biologics Evaluation and Research. "Approved Products – November 20, 2012 Approval Letter – Flucelvax". U.S. Food and Drug Administration (FDA). Archived from the original on December 3, 2012. This article incorporates text from this source, which is in the public domain.
- "Seqirus receives FDA approval for Flucelvax Quadrivalent (Influenza Vaccine) for people four years of age and older" (Press release). Seqirus. May 23, 2016. Archived from the original on January 16, 2017. Retrieved January 15, 2017.
- Roos R (October 14, 2019). "FDA approves first flu vaccine grown in insect cells". Center for Infectious Disease Research and Policy (CIDRAP). Archived from the original on October 14, 2019. Retrieved October 14, 2019.
- "Flublok". U.S. Food and Drug Administration (FDA). February 26, 2018. STN 125285. Archived from the original on October 14, 2019. Retrieved October 14, 2019. This article incorporates text from this source, which is in the public domain.
- "Flublok Quadrivalent". U.S. Food and Drug Administration (FDA). August 2, 2019. STN 125285. Archived from the original on October 14, 2019. Retrieved October 14, 2019. This article incorporates text from this source, which is in the public domain.
- "Supemtek: Pending EC decision". European Medicines Agency (EMA). September 17, 2020. Archived from the original on September 23, 2020. Retrieved September 21, 2020. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
- "Supemtek Product information". Union Register of medicinal products. Archived from the original on March 5, 2023. Retrieved March 3, 2023.
- "Influenza Genome Sequencing Project – Overview". National Institutes of Health – National Institute of Allergy and Infectious Diseases. Archived from the original on June 27, 2011. Retrieved May 27, 2013.
- Lampos V, Yom-Tov E, Pebody R, Cox IJ (2015). "Assessing the impact of a health intervention via user-generated Internet content" (PDF). Data Mining and Knowledge Discovery. 29 (5): 1434–57. doi:10.1007/s10618-015-0427-9. S2CID 215415165. Archived from the original on August 28, 2021. Retrieved August 15, 2022.
- "Acute Respiratory Infections (Update September 2009)". World Health Organization (WHO). September 2009. Archived from the original on September 29, 2009. Retrieved September 16, 2009.
- "Tables on the Clinical trials of pandemic influenza prototype vaccines". World Health Organization (WHO). July 2009. Archived from the original on March 6, 2009. Retrieved September 21, 2009.
- "FDA Approves Vaccines for 2009 H1N1 Influenza Virus" (Press release). September 15, 2009. Archived from the original on October 15, 2009. Retrieved October 15, 2009. This article incorporates text from this source, which is in the public domain.
- Keown A (February 4, 2020). "FDA Approves Seqirus' Audenz as Vaccine Against Potential Flu Pandemic". BioSpace. Archived from the original on February 5, 2020. Retrieved February 5, 2020.
- "Audenz". U.S. Food and Drug Administration (FDA). January 31, 2020. STN: 125692. Archived from the original on August 6, 2020. Retrieved February 5, 2020. This article incorporates text from this source, which is in the public domain.
- Sederstrom J (July 19, 2019). "Researchers Exploring Oral Flu Vaccine and Treatment Options". Drug Topics. Archived from the original on June 8, 2020. Retrieved January 27, 2020.
- Triggle N (October 8, 2021). "Flu jab vital this winter along with Covid vaccine". BBC News. Archived from the original on November 14, 2021. Retrieved August 13, 2022.
- Brownlee S (November 1, 2009). "Does the Vaccine Matter?". The Atlantic. Archived from the original on December 9, 2014. Retrieved December 8, 2014.
- Rabin RC (November 5, 2012). "Reassessing Flu Shots as the Season Draws Near". The New York Times. Archived from the original on November 10, 2016. Retrieved December 30, 2016. 'We have overpromoted and overhyped this vaccine,' said Michael T. Osterholm, director of the Center for Infectious Disease Research and Policy, as well as its Center of Excellence for Influenza Research and Surveillance. 'It does not protect as promoted. It's all a sales job: it's all public relations.'
- Influenza Report (online book) Archived May 10, 2016, at the Wayback Machine chapter Avian Influenza by Timm C. Harder and Ortrud Werner
- equiflunet_vaccines Archived January 10, 2006, at the Wayback Machine
- "UAE Equestrian & Racing Federation". March 22, 2005. Archived from the original on March 22, 2005.
- "FEI guidelines" (PDF). Archived (PDF) from the original on October 26, 2007.
- McNeil Jr DG (May 2, 2006). "Turning to Chickens in Fight With Bird Flu". The New York Times. Archived from the original on November 14, 2012.
- "Bird flu warning over partial protection of flocks". August 16, 2006. Archived from the original on September 26, 2007.
- "FAO Recommendations on the Prevention, Control and Eradication of Highly Pathogenic Avian Influenza (HPAI) in Asia" (PDF). Archived (PDF) from the original on February 2, 2010. Retrieved September 16, 2009.
- "Swine Flu Virus Turns Endemic". September 15, 2007. Archived from the original on April 29, 2009.
- "Custom Vaccines: Swine". Archived from the original on April 30, 2009.
- "Global Influenza Surveillance and Response System (GISRS)". World Health Organization. Archived from the original on October 3, 2011. Retrieved October 22, 2019.
- "Spotlight: Influenza". World Health Organization. Archived from the original on October 18, 2019. Retrieved October 22, 2019.
- "Global influenza surveillance". WHO. Archived from the original on April 30, 2003.
- Brown D (February 18, 2008). "Keeping ahead of flu comes down to guessing game". Knoxville News Sentinel. The Washington Post. Archived from the original on January 11, 2009. Retrieved December 22, 2015.

who.int

"Influenza (Seasonal)". World Health Organization (WHO). November 6, 2018. Archived from the original on October 25, 2019. Retrieved October 24, 2019.
"5 myths about the flu vaccine". World Health Organization. Archived from the original on February 14, 2024. Retrieved June 24, 2024.
Global Advisory Committee on Vaccine Safety (July 14, 2006). "Thiomersal and vaccines". World Health Organization (WHO). Archived from the original on November 6, 2009. Retrieved November 20, 2007.
"Vaccine use". World Health Organization (WHO). Archived from the original on December 15, 2012. Retrieved January 15, 2017.
"Influenza (Seasonal) Fact sheet". World Health Organization (WHO). November 2016. Archived from the original on November 30, 2014. Retrieved January 15, 2017.
"Influenza (Seasonal)". WHO. November 6, 2018. Archived from the original on October 14, 2019. Retrieved October 14, 2019.
"Influenza vaccine viruses and reagents". World Health Organization (WHO). Archived from the original on May 27, 2013.
"Recommendations for the production and control of influenza vaccine (inactivated)" (PDF). World Health Organization (WHO). Archived (PDF) from the original on October 28, 2013. Retrieved May 27, 2013.
"Acute Respiratory Infections (Update September 2009)". World Health Organization (WHO). September 2009. Archived from the original on September 29, 2009. Retrieved September 16, 2009.
"Tables on the Clinical trials of pandemic influenza prototype vaccines". World Health Organization (WHO). July 2009. Archived from the original on March 6, 2009. Retrieved September 21, 2009.
"Global Influenza Surveillance and Response System (GISRS)". World Health Organization. Archived from the original on October 3, 2011. Retrieved October 22, 2019.
"Spotlight: Influenza". World Health Organization. Archived from the original on October 18, 2019. Retrieved October 22, 2019.
"Global influenza surveillance". WHO. Archived from the original on April 30, 2003.

euro.who.int

"Methods for assessing influenza vaccination coverage in target groups (2016)". WHO/Europe. March 19, 2018. Archived from the original on October 14, 2019. Retrieved October 14, 2019.
"Recommendations on influenza vaccination during the 2019–2020 winter season". WHO/Europe. September 24, 2019. Archived from the original on October 14, 2019. Retrieved October 14, 2019.

cdn.who.int

World Health Organization (September 29, 2023). "Questions and Answers: Recommended composition of influenza virus vaccines for use in the southern hemisphere 2024 influenza season and development of candidate vaccine viruses for pandemic preparedness" (PDF). Archived (PDF) from the original on October 10, 2023. Retrieved October 26, 2023.

worldcat.org

Doshi P (September 20, 2018). "Pandemrix vaccine: why was the public not told of early warning signs?". BMJ. 362: k3948. doi:10.1136/bmj.k3948. ISSN 0959-8138. S2CID 52308748.
Centers for Disease Control Prevention (CDC) (August 13, 2004). "Assessment of the effectiveness of the 2003-04 influenza vaccine among children and adults--Colorado, 2003". MMWR. Morbidity and Mortality Weekly Report. 53 (31). Centers for Disease Control and Prevention: 707–710. ISSN 1545-861X. PMID 15306754. Archived from the original on April 27, 2022. Retrieved April 27, 2022. At table.
Centers for Disease Control Prevention (CDC) (January 16, 2004). "Preliminary assessment of the effectiveness of the 2003-04 inactivated influenza vaccine--Colorado, December 2003". MMWR. Morbidity and Mortality Weekly Report. 53 (1). Centers for Disease Control and Prevention: 8–11. ISSN 1545-861X. PMID 14724559. Archived from the original on May 29, 2022. Retrieved April 25, 2022.
Chung JR (March 11, 2022). "Interim Estimates of 2021–22 Seasonal Influenza Vaccine Effectiveness — United States, February 2022". MMWR. Morbidity and Mortality Weekly Report. 71 (10): 365–370. doi:10.15585/mmwr.mm7110a1. ISSN 0149-2195. PMC 8911998. PMID 35271561. Archived from the original on May 16, 2022. Retrieved May 25, 2022.
Thompson MG, Pierse N, Huang QS, Prasad N, Duque J, Newbern EC, et al. (September 18, 2018). "Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012–2015". Vaccine. 36 (39): 5916–5925. doi:10.1016/j.vaccine.2018.07.028. ISSN 0264-410X. PMID 30077480. S2CID 51922011. Archived from the original on May 27, 2022. Retrieved April 23, 2022.
Tenforde MW, Talbot HK, Trabue CH, Gaglani M, McNeal TS, Monto AS, et al. (December 30, 2020). "Influenza Vaccine Effectiveness Against Hospitalization in the United States, 2019–2020". The Journal of Infectious Diseases. 224 (5): 813–820. doi:10.1093/infdis/jiaa800. ISSN 0022-1899. PMC 8408767. PMID 33378531. Archived from the original on April 23, 2022. Retrieved April 23, 2022.
Ferdinands JM, Thompson MG, Blanton L, Spencer S, Grant L, Fry AM (June 23, 2021). "Does influenza vaccination attenuate the severity of breakthrough infections? A narrative review and recommendations for further research". Vaccine. 39 (28): 3678–3695. doi:10.1016/j.vaccine.2021.05.011. ISSN 0264-410X. PMID 34090700. S2CID 235361401. Archived from the original on April 23, 2022. Retrieved April 23, 2022.
Gemmill I, Young K (June 7, 2018). "Summary of the NACI literature review on the comparative effectiveness of subunit and split virus inactivated influenza vaccines in older adults". Canada Communicable Disease Report. 44 (6): 129–133. doi:10.14745/ccdr.v44i06a02. ISSN 1481-8531. PMC 6449119. PMID 31015805. Archived from the original on May 17, 2020. Retrieved June 2, 2020.
Wells C, Grobelna A (January 8, 2019). "High Dose Influenza Vaccine for Adults: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines" (PDF). Rapid Response Report. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). ISSN 1922-8147. PMID 31141324. Archived (PDF) from the original on August 1, 2020. Retrieved August 15, 2022.

youtube.com

Izzat F (April 2012). "Viral Cultivation in Chicken Embryo". Youtube. Archived from the original on May 26, 2015.

zenodo.org

Vellozzi C, Burwen DR, Dobardzic A, Ball R, Walton K, Haber P (March 2009). "Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring". Vaccine. 27 (15): 2114–20. doi:10.1016/j.vaccine.2009.01.125. PMID 19356614. Archived from the original on August 1, 2020. Retrieved May 21, 2020.

Influenza vaccine (English Wikipedia)

162.216

195.224.162.216

abc.net.au

archive-it.org

wayback.archive-it.org

archive.org

astrazeneca.ca

bbc.com

biospace.com

books.google.com

cadth.ca

canada.ca

cdc.gov

clinicaltrials.gov

doi.org

drugs.com

drugtopics.com

ecbt.org

europa.eu

ecdc.europa.eu

ema.europa.eu

ec.europa.eu

europeanpharmaceuticalreview.com

fao.org

fda.gov

handle.net

hdl.handle.net

harvard.edu

ui.adsabs.harvard.edu

haverford.edu

healio.com

healthdirect.gov.au

horsesport.org

hpfb-dgpsa.ca

dhpp.hpfb-dgpsa.ca

hres.ca

hpr-rps.hres.ca

influenzareport.com

knoxnews.com

lohmann-breeders.com

medicalnewstoday.com

nationalhogfarmer.com

nbcnews.com

newsweek.com

nhs.uk

nih.gov

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

nih.gov

niaid.nih.gov

novartis.com

livestock.novartis.com

npr.org

nsw.gov.au

health.nsw.gov.au

nytimes.com

nytimes.com

well.blogs.nytimes.com

oecd.org

data.oecd.org

oup.com

academic.oup.com

path.org

phac-aspc.gc.ca

prnewswire.com

psu.edu

citeseerx.ist.psu.edu

publications.gc.ca

reuters.com

sanofi.us

news.sanofi.us

scidev.net

sciencebasedmedicine.org

sciencedirect.com

semanticscholar.org

api.semanticscholar.org

seqirus.com

seqirus.us

tga.gov.au